[{"article": "\"We all believe that we want to see more data.\nThe fraction of babies with defects was 7.1 percent in the ACE-inhibitor group; 1.7 percent in the other anti-hypertensive group; and 2.6 percent in the group taking no blood-pressure medication.\nOf that group, 209 babies were born to women who took an ACE inhibitor, and 18 had birth defects.\n\"I think it is safe to say that not a lot is known about the options for women in pregnancy,\" said Sandra L. Kweder of the FDA's Center for Drug Evaluation and Research.\nOne-third of the defects involved the heart, one-quarter the limbs or face, and one-tenth the brain or spinal cord, the study found.\n", "question": "Does the story commit disease-mongering?", "explanation": "This article does not appear to disease monger. Although it does mention that these drugs \u2018nearly tripled\u2019 the rate of birth defects, it also attempted to lay out the numbers for what this really meant. But it botched the percentages. The story presents the rate of birth defects for women not taking blood pressure medication as 2.6%, though the data in the New England Journal of Medicine reported that there were 4 out of 202 infants born with birth defects in this group \u2013 which is 1.98%. The story mentioned that the rate of birth defects for those who had taken ACE inhibitors during the first trimester of pregnancy was 7.1%, though the journal article reported that there were 18 out of 209 in this group or a birth defect rate of 8.6%.\nThe article did not note that the data reported on the rate of birth defects after ACE inhibitor use during the first trimester only.", "answer": 1}, {"article": "But another found that the stroke rate was 22 percent lower in people who ate chocolate once a week, and a third reported that death from stroke was 46 percent lower in those who ate 50 grams of chocolate once a week.\nBut the findings, based on a review of existing research, aren't conclusive, and they don't prove that chocolate is good for your heart.\nFor one thing, it's possible that some factor other than chocolate could be helping lower the risk of stroke.\n\"Today, we know that all chocolates are not the same.\"\nAnd dietitians say too much chocolate can be harmful.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story didn\u2019t tell us anything about stroke, so it couldn\u2019t commit disease-mongering. ", "answer": 2}, {"article": "The requested URL /usnews/health/articles/070805/13knee.htm was not found on this server.", "question": "Does the story commit disease-mongering?", "explanation": "There are no obvious elements of disease-mongering. An extra sentence could have explained that knee osteoarthritis is a degenerative condition afflicting mostly older men and women.", "answer": 1}, {"article": "Medtronic Inc. and Eli Lilly & Co. agreed to collaborate on an early stage research project for a potential Parkinson's-disease treatment that involves delivering medication directly to the brain\u2014a goal that has long eluded drug makers.\n\nThe pact, announced Tuesday, adds to Medtronic's roster of projects aimed at using implantable drug pumps and catheters to circumvent the blood-brain barrier. The tightly packed network of cells in brain capillaries only lets certain substances through, such as key nutrients, making brain-based...", "question": "Does the story commit disease-mongering?", "explanation": "There was no disease-mongering in the story.", "answer": 1}, {"article": "Research reported prior to 2004 had suggested that the stroke risk is 10 percent two days after mini-stroke symptoms appear and between 8 percent and 20 percent for the 30- to 90-day period after symptom onset.\n\u201cYou should worry about symptoms even if they last for just a few seconds or a few minutes,\u201d Amarenco said.\nThe study was also noteworthy because, over the long haul, patients did a particularly good job of taking the medications they were given.\n\u201cThe study showed that the widespread, systematic implementation of specialized TIA units across multiple sites, countries, and continents can make a difference in the care of these patients,\u201d write Drs.\nOne year after symptoms, the stroke rate was 5.1 percent.\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease mongering here.", "answer": 1}, {"article": "FODMAPs are a group of carbohydrates that don\u2019t get broken down and absorbed in the small intestine.\nGibson estimates that, overall, about 10 percent of the population may be FODMAP-sensitive.\n\u201cFollowing strictly the low-FODMAP diet is associated with changes in the microbiota that many would not equate with good health,\u201d says Gibson, who stresses that a low-FODMAP diet should be used to reduce specific symptoms, not as a way to improve health.\nIf your gut can handle FODMAPs, foods that contain a lot of them can be very good choices \u2014 partly because the fermentation helps your gut biome and partly because the way FODMAPs are digested means you\u2019re absorbing fewer calories than indicated on a FODMAP-rich product\u2019s label.\nThey may assume that they have gluten sensitivity, but some researchers believe that it\u2019s not the gluten they\u2019re sensitive to.\n", "question": "Does the story commit disease-mongering?", "explanation": "We\u2019d like to rate the article satisfactory here, since it does counter widely held views about the prevalence of gluten sensitivity that are inaccurate. However, it\u2019s possible that disease-mongering of gluten sensitivity is being replaced by disease-mongering of FODMAPS. We are told that 10% of the population has a problem with foods high in FODMAPs, but we aren\u2019t provided with any validation of that statistic.", "answer": 0}, {"article": "British researchers led by David Nutt, a professor of neuropsychopharmacology at Imperial, have been exploring the potential of psilocybin to ease severe forms of depression in people who don\u2019t respond to other treatments.\nRobin Carhart-Harris, who led the study at Imperial College London\u2019s department of medicine, said the results, published in the Lancet Psychiatry journal, were striking.\nA small-scale pilot study of psilocybin\u2019s use in cases of treatment-resistant depression showed it was safe and effective, the British researchers said.\n\u201cI wouldn\u2019t want members of the public thinking they can treat their own depressions by picking their own magic mushrooms.\nThe trial involved six men and six women, aged between 30 and 64, all diagnosed with treatment-resistant depression.\n", "question": "Does the story commit disease-mongering?", "explanation": "Treatment-resistant depression is truly a serious condition.", "answer": 1}, {"article": "After her mother unexpectedly died from a tear in the wall of her heart at age 63, Patricia Walters talked to her doctor, Leslie Cho, about how to better monitor her own heart health.\n\nPregnant at the time with her own daughter, Ms. Walters, now 46, says she was \"a nervous wreck\" worrying that she, too, might face serious cardiac risk.", "question": "Does the story commit disease-mongering?", "explanation": "We think that statements such as, \u201cAnd one major study suggests that even people with minimal risk factors in their late 50s and early 60s should have the test\u201d and \u201cBut genetic factors can also contribute to elevated CRP in people without traditional risk factors\u201d would leave many readers with the impression that just about everyone needs to have the test performed.\nFor the record, the US Preventive Services Task Force states: \u201cThe U.S. Preventive Services Task Force (USPSTF) concludes that the evidence is insufficient to assess the balance of benefits and harms of using the nontraditional risk factors (including\u00a0high-sensitivity C-reactive protein \u2013 hs-CRP) \u2026to screen asymptomatic men and women with no history of CHD to prevent CHD events.\u201d ", "answer": 0}, {"article": "In a new study, imaging scans showed that regular fish-eaters were less likely to have brain cells die off in the area of the brain responsible for short-term memory -- recalling a phone number that was just heard, for example.\nRaji presented the findings here at the annual meeting of the Radiological Society of North America.\n\"More fish, more brain, less Alzheimer's,\" he tells WebMD.\nNov. 30, 2011 (Chicago) -- Older people who eat baked or broiled fish at least once a week may be boosting their brain health.\n\"The new study is the first to establish a direct relationship between fish consumption, brain structure, and Alzheimer's risk,\" Raji says.\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease mongering of Alzheimer\u2019s disease.\n ", "answer": 1}, {"article": "\u2022 Ovarian cysts may occur but usually disappear.\n2015.\nOnly you and your healthcare provider can decide if Kyleena is right for you.\nKyleena is available by prescription only.\n1Kyleena Prescribing Information, September 2016.\n", "question": "Does the news release commit disease-mongering?", "explanation": "No disease mongering here.", "answer": 1}, {"article": "That number was the same in younger people who had large waistlines, and even lower in those with metabolic syndrome, a combination of risk factors including belly fat, high blood pressure and high blood sugar.\nAs a result, he said, it is hard to know whether removing polyps in younger people would in turn lower their risk of getting cancer.\nLeFevre, a member of the U.S. Preventive Services Task Force, a federally appointed expert panel, said the chances that a polyp turns into cancer is currently a matter of debate.\nA camera at the tip shows the inside of the gut, so that unusual cell clumps can be found and removed.\nColonoscopy, used in millions of Americans every year, is just one of many methods to detect abnormalities.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story does not exaggerate the seriousness or prevalence of polyps or colon cancer. The story clearly states that most polyps do not develop into cancer.", "answer": 1}, {"article": "The Lancet.\nThe study suggests that one hip fracture could be prevented for every 111 women screened and early analysis suggests the approach is likely to be cost-effective.\nIn the screening group, there were 54 fewer women who suffered one or more hip fractures compared to the routine care group.\nThis recommendation was acted upon by the women and their GPs so that over three quarters of the women at high risk were on osteoporosis medications within six months of screening.\nAmong those screened, treatment was subsequently recommended for one in seven women deemed at high risk of hip fracture.\n", "question": "Does the news release commit disease-mongering?", "explanation": "The release takes a balanced approach to the severity of the health issue under study. There is no disease mongering. Hip fractures are common and are associated with poor outcomes \u2014 disability, loss of independence, and death.", "answer": 1}, {"article": "\u201cIt\u2019s easier to pop a pill,\u201d Dr. Altman said.\n\u201cFuture research needs to be done using patients with co-morbidities to know that these agents are safe in the highest-risk population,\u201d said the author of the analysis, Dr. Una Makris, an associate research scientist at the Yale School of Medicine.\nThe main advantage of a skin cream is that it bypasses the stomach and much of the bloodstream, theoretically minimizing serious side effects.\nThe topical painkillers are not for everyone.\n\u201cI think many people are not aware of topical Nsaids, or there is a perception that they don\u2019t work well, or people confuse topical Nsaids with other topical drugs, like the topical salicylates or capsaicin,\u201d Dr. Chou said.\n", "question": "Does the story commit disease-mongering?", "explanation": "1clip_filelist.xml\"/>\n\n\n\nThe story does not exaggerate the common pains these drugs are intended to treat, but the personal anecdotes and opinions highlighted at the beginning and ending of the story are unrepresentative of the typical experiences reported by participants in clinical trials and create a powerful impression that is at odds with the evidence.", "answer": 0}, {"article": "Feb. 22, 2012 -- When women in their 40s get breast cancer , their tumors need less intense treatment and recur less often if they were first detected during routine mammogram screening.\n\"They get more breast -conserving surgery and less chemotherapy .\"\nBut the picture isn't so clear for women in their 40s.\nBrawley says.\nThese women will suffer the harms of early screening.\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease mongering.", "answer": 1}, {"article": "...\nAt some doses, the medication lisdexamfetamine dimesylate, a drug approved to treat attention-deficit/hyperactivity disorder, was effective compared with placebo in decreasing binge-eating (BE) days in patients with binge-eating disorder (BED), a public health problem associated symptoms of mental illness and obesity and for which there are no approved medications, according to a study published online by JAMA Psychiatry.\nThe one-week BE episode response status was improved in the 50- and 70-mg/d treatment groups, and a greater proportion of participants achieved four-week cessation of BE episodes and global improvement of symptom severity with all lisdexamfetamine dosages.\nSusan L. McElroy, M.D., of the Research Institute, Lindner Center of HOPE, Mason, Ohio, and coauthors compared lisdexamfetamine with placebo in adults with moderate to severe BED in a randomized clinical trial from May 2011 through January 2012.\nSimilarly, BE episodes decreased in the 50- and 70-mg/d treatment groups.\n", "question": "Does the news release commit disease-mongering?", "explanation": "Although the news release is free of emotionally wrenching\u00a0words or phrases, binge-eating disorder\u00a0itself would be considered by some to be an example of disease mongering. It is essentially a problem of overeating, differentiated from other psychiatric eating disorders (anorexia and bulimia) by the lack of purging or fasting to compensate for the overeating. It was originally codified as a disorder\u00a0worthy of further study in DSM-IV, by a work-group that was heavily involved with industry. DSM-V added it as an official diagnosis. The eating disorders work-group had become less conflicted, but still 50% of members reported COIs.\nGiven the nation\u2019s obsession with weight and overeating, one can see how many people will be convinced they have this disorder. In the buildup to the drug\u2019s expanded approval, drugmaker Shire played an active role marketing awareness of binge-eating disorder, as The New York Times reported.", "answer": 1}, {"article": "The F.D.A.\nMr. Girgus, 65, who also owns Dendreon stock, said patients like himself were \"looking into the abyss.\"\nJudy Leon, a spokeswoman for the F.D.A., said the agency sympathized with patients but that it was necessary for drugs to meet agency standards for safety and efficacy.\nThe F.D.A.\u2019s decision two years ago ignited an outcry from some prostate cancer patients and from investors in Dendreon, who said the agency was being unreasonable and denying patients a treatment that might work.\nDr. Gold said there were about 100,000 men who get such a diagnosis each year.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story quotes the drug maker\u2019s chief executive estimating that 100,000 American men per year are diagnosed with cancer that has spread beyond the prostate gland and is not benefitting from other therapies. \nThe reporter should not have depended on this self-interested source. \nOther news stories, quoting a variety of independent sources, estimated the number of affected men at 40,000 to 60,000 per year.\u00a0 \nIn addition, the reporter allows a source with dual conflicts of interest\u2013he is a patient who could benefit from the treatment and a stockholder in the company that makes the drug\u2013to make emotional appeals for approval.\nHe says many men have been \"lost\" since the FDA\u2019s failure to approve the drug, and that he and other patients are \"looking into the abyss\" and just \"want a chance\" to live. ", "answer": 0}, {"article": "The beneficial effects of traditional acupuncture, according to the researchers, did not appear to be associated with changes in levels of hormones that trigger menopause and its associated symptoms.\nAfter 10 weeks, the women in the traditional acupuncture group had significantly less severe hot flashes and mood swings than those who'd gotten the fake treatment.\nThe findings were published online March 7 in Acupuncture in Medicine.\nThe research included 53 postmenopausal women, with about half receiving traditional Chinese acupuncture twice a week and the others given sham acupuncture treatments.\nThere were no differences between the two groups in terms of vaginal dryness and urinary tract infection.\n", "question": "Does the story commit disease-mongering?", "explanation": "No overt disease mongering.\u00a0 Although the story made no attempt to explain how troublesome the study subjects\u2019 symptoms were before the intervention.", "answer": 1}, {"article": "Not a single cancer was undetected that became palpable,\" she said.\nHowever, with breast cancer remaining a major cause of cancer death in women, there is good reason to pursue the search for improved screening methods, according to the study's lead author, Christiane Kuhl, M.D., chair of the Department of Radiology at RWTH Aachen University in Aachen, Germany.\nAdditional cancers detected by MRI screening in the study had a skewed distribution towards a higher-than-normal prevalence or incidence of rapidly growing (grade 3) cancers.\nAccording to Dr. Kuhl, interval cancers exhibit an adverse biologic profile and are the main driver of breast cancer mortality.\nOf the 60 cancers detected in the study group over the observation period (7,007 screening rounds), 59 were found only using MRI, one was found also by mammography, and none by mammography or ultrasound alone.\n", "question": "Does the news release commit disease-mongering?", "explanation": "Breast cancer\u2019s prevalence in cancer-related deaths in women\u00a0was highlighted but not overstated.\nBut we aren\u2019t told whether the 20 cases of non-invasive cancer identified were ductal carcinoma in situ (DCIS). There\u2019s wide debate on whether the presence of these types of abnormal cells should even be referred to as cancer. The lack of clarity on the types of cancer identified and the difference between them earns a Not Satisfactory rating. ", "answer": 0}, {"article": "\u201cIt suggests that a balanced multivitamin approach is probably more beneficial than increasing to high levels any one vitamin.\u201d\n\nAbout half of U.S. adults take at least one daily dietary supplement - the most popular being a multivitamin, according to the U.S. Centers for Disease Control and Prevention.\nThe findings were published in the Journal of the American Medical Association and presented on Wednesday at a meeting of the American Association for Cancer Research in Anaheim, California.\nThey also saw a 12 percent reduction in the risk of death from cancer, although those findings also were not statistically significant.\nThe research was sponsored by the National Institutes of Health.\n\u201cOur trial took a very commonly used multivitamin that has basically low levels of all the different essential vitamins and minerals.\u201d\n\nThe findings suggest that the biggest health benefit may come from a broad combination of dietary supplements, he said.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story points out that the participants were healthy middle-aged men. There was no disease-mongering of cancer.", "answer": 1}, {"article": "But she added, \u201cThe community hopes that if telaprevir is approved by the F.D.A.\nThe virus is transmitted by blood, so most people who have hepatitis C either have injected illegal drugs or received blood transfusions or blood products before the early 1990s.\nBut experts hope that eventually several of the pills now in development could be used together, much as AIDS is treated, doing away with the need for interferon.\nSome 2.7 million to 3.9 million Americans are estimated to have hepatitis C, and 12,000 die from it each year, according to a recent report by the Institute of Medicine.\nThat shorter time line, plus a higher chance of success, could entice more people to be treated, experts say.\n", "question": "Does the story commit disease-mongering?", "explanation": "The description of the scope of the disease is fairly standard and well sourced. \"Some 2.7 million to 3.9 million Americans are estimated to have hepatitis C, and 12,000 die from it each year, according to a recent report by the Institute of Medicine. The disease can cause cirrhosis, which is a scarring of the liver, as well as liver cancer. The virus is transmitted by blood, so most people who have hepatitis C either have injected illegal drugs or received blood transfusions or blood products before the early 1990s.\" We wish we\u2019d seen a source on the idea that most recent Hep C patients have injected illegal drugs.", "answer": 1}, {"article": "Kite Pharma is racing to get the first FDA approval of an experimental gene therapy to fight cancer.\n\nAn experimental gene therapy that turns a patient\u2019s own blood cells into cancer killers worked in a major study, with more than one-third of very sick lymphoma patients showing no sign of disease six months after a single treatment, its maker said Tuesday.\n\nIn all, 82 percent of patients had their cancer shrink at least by half at some point in the study.", "question": "Does the story commit disease-mongering?", "explanation": "The story did not disease monger. These lymphomas are serious and aggressive forms of blood cancer.", "answer": 1}, {"article": "S. Bagla; R. Piechowiak; T. Hartman; J. Orlando; A. Isaacson; Vascular Institute of Virginia, Woodbridge, VA; UNC Chapel Hill, Chapel Hill, NC; University of North Carolina, Chapel Hill.\nWhile preliminary data shows that the treatment does work and is feasible, it has only been used in a clinical trial setting.\nTogether the scales represent an 80 percent improvement in function compared with pre-procedure conditions.\nThe treatment was successfully completed in all 13 patients, with no adverse events.\nThis study builds on the growing international research around GAE and osteoarthritis.\n", "question": "Does the news release commit disease-mongering?", "explanation": "The release doesn\u2019t engage in disease mongering.", "answer": 1}, {"article": "How the Breath Test WorksThe process of breath analysis is relatively simple.\n\u201cThe technology is pretty robust.\nNow the test is being used to monitor for disease recurrence.\nOur next step is getting approval from the FDA.\u201d\n\nNote: This work was supported by the Coulter Foundation, V Foundation, National Science Foundation, and Bill and Melinda Gates Foundation.\n\u201cThis study confirms that the technology is accurate.\u201d\n\nLung cancer is the leading cause of cancer death.\n", "question": "Does the news release commit disease-mongering?", "explanation": "There\u2019s no disease-mongering here.", "answer": 1}, {"article": "A capsule of Probiotic Immunity from New Chapter Inc., based in Brattleboro, Vt., contains 1 billion each of 10 different organisms, including Streptococcus salivarius subsp. thermophilus and Lactobacillus acidophilus, two species of bacteria often found in yogurt. Other ingredients include herbs such as cumin, ginger and spinach. Users are instructed to take two capsules each day, preferably one in the morning and one in the evening, on an empty stomach. You can buy a bottle of 90 capsules for about $20 at many health food stores.", "question": "Does the story commit disease-mongering?", "explanation": "No disease mongering.", "answer": 1}, {"article": "While the difference in results for real versus fake acupuncture was small, it suggests acupuncture could have more than a psychological effect, said lead author Andrew Vickers, a cancer researcher at Memorial Sloan-Kettering.\nSome believe its only powers are a psychological, placebo effect.\nSeveral weekly sessions are usually involved, typically costing about $60 to $100 per session.\nDeciding specifics is being left up to the states.\nThe new analysis was published online Monday in Archives of Internal Medicine.\n", "question": "Does the story commit disease-mongering?", "explanation": "No mongering of diseases here.", "answer": 1}, {"article": "The use in spine surgery of bone-growth proteins like Medtronic Inc.\u2019s product Infuse has led to widespread nationwide increases in hospital charges ranging from 11% to 41% above conventional surgical costs, researchers found.\n\nThe researchers studied the results of a broad U.S. sample of 328,000 spine surgeries from 2002 through 2006. They report their findings this week in JAMA, the Journal of the American Medical Association.", "question": "Does the story commit disease-mongering?", "explanation": "The story does not engage in disease mongering. ", "answer": 1}, {"article": "Scientists have found an unexpected use for virtual reality headsets: to help pinpoint people who may later develop Alzheimer\u2019s disease.\nNot all will be destined to be affected by the disease, however.\nChan\u2019s project aims to find out who will.\nThose who do worse in the tests will be the ones most likely to succumb to Alzheimer\u2019s later in life, scientists now believe.\nThese studies used tablet computers to test navigational tasks.\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease mongering here.", "answer": 1}, {"article": "Is this stuff working?\"\nOne report that impressed him involved 28 patients in Korea who were treated for advanced lung cancer \u2013 just like Stevens, who had to wait six weeks to learn whether it was working.\nGraham said there are maybe a dozen published human studies so far, most involving too few patients to draw a firm conclusion.\nThe hope is that, over time, FLT PET would prove reliable for giving a faster answer on whether an experimental treatment is working.\nWhen Mike Stevens learned his lungs were riddled with cancer, it took only a week to start chemotherapy \u2013 but six weeks to find out if it was doing any good.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story dramatizes one patient\u2019s story in a way that overemphasizes the emotional impact not of treatment, but of having to wait for weeks or longer to learn whether a cancer treatment is working. It suggests the novel use of PET scans could \"shorten [the patient\u2019s] stay in purgatory\" by providing an answer \"possibly within days.\"\nThe writer uses loaded language to describe the patient\u2019s status, and at the end includes a vivid, dramatic quote in which the patient who did not have access to this PET scan technology compares his situation to \"having a rope tied around you and you\u2019re leaning over a canyon at about a 45-degree angle, and you don\u2019t know if someone is going to pull you back in. . . \"\u00a0\nWe have no idea whether the patient is receiving the experimental treatment. We learn later that he was diagnosed in 2005 and that with conventional treatments his cancer has remained stable.\u00a0\nThe overall effect is to magnifity the problem and overpromise a solution\u2013a nearly \"perfect\" illustration of disease-mongering.", "answer": 0}, {"article": "\"There really isn't anything else that can reduce a woman's risk by this much.\"\nHowever, \"what our findings show is that women who choose to have these surgeries will reduce their risk of dying of breast or ovarian cancer by about 70 to 80 percent, which is pretty profound,\" said study senior author Dr. Timothy Rebbeck, a professor of epidemiology at the University of Pennsylvania School of Medicine.\n\"These findings really emphasize how important it is for all women with a family history of early breast or ovarian cancer to undergo genetic testing,\" said Dr. Virginia Kaklamani, co-author of an editorial that accompanied the study.\nKaklamani added that she hoped the findings would encourage more women to ask their primary care physicians whether they are candidates for genetic counseling.\nTUESDAY, Aug. 31, 2010 (HealthDay News) -- Women who carry genetic mutations that boost their odds of breast and ovarian cancer can live longer and reduce their cancer risk by having preventive surgery, a new study suggests.\n", "question": "Does the story commit disease-mongering?", "explanation": "1clip_filelist.xml\" rel=\"File-List\"/>\n\n\n\nThe story makes clear that the study findings are relevant specifically to women who have been told that they carry BRCA1/2 genetic mutation that substantially increase their risk of cancer. It compares the lifetime risk estimates of women with the mutations and those in the general population. It also includes comments from experts saying that women who have a family history of cancer should talk to their physicians about whether they should consider genetic testing, thus highlighting the distinction between family history and the specific gene mutations looked at in this study. Also, as mentioned in the summary, the gene mutations are present in less than 3 percent of women who have just a single relative who had breast cancer, so the quote urging all women with a family history of breast cancer presents an extremely aggressive position.", "answer": 1}, {"article": "Professor Marianne Thoresen said: \"Even if we account for a lesser severity of perinatal asphyxia, our research has shown that therapeutic hypothermia reduces the number of children who develop epilepsy later in childhood.\nThe research was funded by Sparks UK; University of Bristol's Alumni Foundation; The Laerdal Foundation for Acute Medicine, Norway; University of Oslo, and a private donation.\nThe research team has developed and delivered cooling treatment, known as therapeutic hypothermia, for newborns who suffer lack of oxygen during birth.\nThe study has been led by Marianne Thoresen, Professor of Neonatal Neuroscience, from the Bristol Medical School: Translational Health Sciences at the University of Bristol.\nThe patients' cognitive performance, life quality and life expectancy is also affected by having the condition.\n", "question": "Does the news release commit disease-mongering?", "explanation": "No disease mongering here.", "answer": 1}, {"article": "Drinking cow\u2019s milk produced at night may be a treatment for anxiety and insomnia, suggests an animal study in the Journal of Medicinal Food.\n\nA glass of milk at bedtime has long been touted as a sleep aid. But the study found that milk collected at night, or night milk, had enhanced sedative effects in mice compared with milk produced during the day. Night milk significantly decreased the rodents\u2019 physical activity, balance and coordination and increased sleep time compared with day milk, the research showed.", "question": "Does the story commit disease-mongering?", "explanation": "No disease-mongering going on here.", "answer": 1}, {"article": "He predicted that information gained from the trial after the results are fully analyzed will have \"important implications for the design of future HIV vaccines.\"\nThat the vaccine is at least nominally a success comes as a surprise.\nThe results were barely significant on statistical grounds, perplexing for scientific reasons and unanticipated by most researchers.\nBut at least we know it can be done.\"\n\"It is in a kind of gray zone, and I think we should really get the data and look at it and see what it all means.\"\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease-mongering in this story. ", "answer": 1}, {"article": "Computed tomography coronary angiography (CTCA), is a high-resolution X-ray of the heart that can be used to diagnose the reason for angina, or chest pain, symptoms and clarify what other treatments might be needed.\nThis reflects the fact that the cause of the symptoms had been unknown before and in addition they now have heart artery disease that needs treatment, Newby said.\n\u201cCertainly, this is something we now discuss in more detail with our patients, some of whom have declined CTCA.\u201d\n\n\u201cIt was striking for me that health status was very much related to receiving a (treatable) diagnosis or excluding such a diagnosis, rather than experiencing angina symptoms per se,\u201d said Dr. Paula M. C. Mommersteeg from the Center of Research on Psychology in Somatic Diseases, Tilburg University, The Netherlands, who has investigated associations between personality traits and coronary artery disease symptoms.\n\u201cThis suggests that being reassured that all is normal is highly valued by patients and CTCA really helps provide this reassurance.\n\u201cIn my opinion, CTCA does have added value in the diagnostic process (improved decision making), it is less invasive than coronary angiography (CAG), and can provide more clarity in the cardiac symptoms experienced by patients,\u201d Mommersteeg concluded.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story reports that the researchers were looking at CTCA testing only for specific patients who had already been given a diagnosis related to chest pain. Readers would likely understand that the CTCA test was being offered only to certain patients to clarify their diagnoses, not something that would be recommended to people who were not already being tested or treated for chest pain that might be caused by heart disease. The article might have added a bit more clarification on who the test was intended to help.", "answer": 1}, {"article": "After 78 weeks, they found that patients given bapineuzumab had about a 25 percent reduction in plaque compared with those on placebo.\nThe new study, which only involved 28 patients, is modest fillip.\nBut a rival school blames toxic tangles caused by an abnormal build-up of the protein tau.\nThe drug\u2019s developers have since dropped the top dose from large ongoing Phase III trials.\nRinne\u2019s imaging study was funded by Elan and Wyeth, which is now part of Pfizer.\n", "question": "Does the story commit disease-mongering?", "explanation": "\u00a0The story did not engage in overt disease mongering.", "answer": 1}, {"article": "1 in hospitals.\u201d\n\nAccording to the Centers for Disease Control and Prevention, C. difficile infects half a million people in the United States per year and kills 15,000 people.\nThere was a significant difference in cost.\n\u201cIt\u2019s absolutely insane.\n\u201cStool is such a complex mixture.\u201d\n\u201cIt is our public enemy No.\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease mongering here.", "answer": 1}, {"article": "Leukemia is the most common childhood cancer and accounts for about 30 percent of all childhood cancers.\nIn addition, more high-quality studies are needed to clarify the biological mechanisms underlying this association between breastfeeding and lower childhood leukemia morbidity,\u201d the study concludes.\nTo place an electronic embedded link to this study in your story Links will be live at the embargo time: http://archpedi.jamanetwork.com/article.aspx?doi=10.1001/jamapediatrics.2015.1025\n\nBreastfeeding for six months or longer was associated with a lower risk of childhood leukemia compared with children who were never breastfed or who were breastfed for a shorter time, according to an article published online by JAMA Pediatrics.\n\u201cBecause the primary goal of public health is prevention of morbidity, health care professionals should be taught the potential health benefits of breastfeeding and given tools to assist mothers with breastfeeding, whether themselves or with referrals to others who can help.\nThe authors suggest several biological mechanisms of breast milk may explain their results, including that breast milk contains many immunologically active components and anti-inflammatory defense mechanisms that influence the development of an infant\u2019s immune system.\n", "question": "Does the news release commit disease-mongering?", "explanation": "The release states that \u201cLeukemia is the most common childhood cancer and accounts for about 30 percent of all childhood cancers.\u201d \u00a0And it suggests that breastfeeding can prevent these leukemias, which has the potential to make mothers feel badly if they\u2019re unable to successfully breastfeed (a common phenomenon). But the release never provides the comforting information that cancer in children is, according to the National Cancer Institute, a \u201crare\u201d disease. This is important context.", "answer": 0}, {"article": "Tobacco use accounts for some 85 percent of lung cancer cases in the U.S., and one estimate puts a smoker\u2019s lifetime absolute risk of developing lung cancer between 12 percent and 17 percent.\nThat previous finding was \u201cvery good news in the field,\u201d said Dr. Bruce Johnson of the Dana Farber Cancer Institute, who treats lung cancer patients and reviewed the results for Reuters Health.\nAnd for lung cancer, doctors know there is a high false-positive rate and have a set protocol to follow in order to determine which lesions are dangerous, added Johnson.\nHer ideas were controversial to start with, especially when other researchers found her work had been paid for by a tobacco company.\nThe high so-called \u201cfalse positive\u201d rate is an issue, said Dr. James Hanley of McGill University, who also reviewed the findings for Reuters Health, but many mammograms also find lesions that turn out to be benign.\n", "question": "Does the story commit disease-mongering?", "explanation": "\n\n\nThe story reports credible numbers describing the toll of lung cancer. ", "answer": 1}, {"article": "Red and purple fruits owe their colors to...\nMuch of the popularity is the work of a California-based company, Pom Wonderful.\nBut is it especially healthful?\nThe Pomegranate is hot.\nAlthough it's a challenge to eat the raw fruit without getting a mouthful of seeds and astringent pith, pomegranates are everywhere now in the form of juice, concentrates and extracts, all heavily promoted for better health.\n", "question": "Does the story commit disease-mongering?", "explanation": "This article did not contain obvious elements of disease-mongering.", "answer": 1}, {"article": "In a statement, Dr. Lesley Russell, Cephalon's chief medical officer, said:\n\nThe most common side effects for Nuvigil, include diarrhea, headache, insomnia and nausea, according to Cephalon.\nSo who wouldn't want a pill to fight the doldrums caused by skipping too many time zones too fast?\nWell, the Food and Drug Administration.\nCephalon soldiered on, giving FDA more data.\nBut the regulators weren't buying the evidence put forward by the company to prove the medicine's benefits in treating travelers' \"excessive sleepiness\" outweighed its risks.\n", "question": "Does the story commit disease-mongering?", "explanation": "There was no disease-mongering.", "answer": 1}, {"article": "\"For the controls, even without having their immune systems 'educated' towards HER2 specifically, they may still mount a response because they have previously seen HER2 within their own cancer,\" Hale said.\nNumerous vaccines to prevent breast cancer recurrence are currently under study, he noted.\nThe study involved 217 breast cancer survivors who had gone through their treatment and were free of disease at the start of the trial.\nThe women received monthly injections for six months.\nThose who were vaccinated also displayed a decrease in certain cells that suppress the immune system.\n", "question": "Does the story commit disease-mongering?", "explanation": "There was no disease-mongering of HER2-positive breast cancers.", "answer": 1}, {"article": "During a salvage radical prostatectomy, the prostate gland and surrounding tissue are surgically removed to keep the cancer from spreading.\n\"However, this study shows that it is a viable treatment option.\nThis can bring a renewed hope and peace of mind to men living with prostate cancer.\"\n\"Because radical prostatectomy is a complex surgery, there can be a reluctance to undergo the procedure,\" Pokala said.\nCOLUMBIA, Mo.\n", "question": "Does the news release commit disease-mongering?", "explanation": "There was no disease mongering.", "answer": 1}, {"article": "\u201cOur lab is on an island in the South.\nThis information is in the early stages of transforming the category of after-sun care\u2014a category traditionally limited to aloe vera-laden moisturizers and gels that lowered the temperature of sun-parched skin but not much else.\nMs. Peterson, a former marketing executive, began to explore the use of all-natural products several years ago after surviving melanoma, the most serious type of skin cancer.\n\u201cThat can make sun-exposed skin feel better,\u201d she said, \u201cBut there\u2019s nothing you can do to reverse sun exposure.\u201d And while Henry Lim, president of the American Academy of Dermatology, believes that the Yale study was important, he cautions that you only have a three-hour window after sun exposure to take advantage of any potential product benefits\u2014and that antioxidants \u201care notoriously not very stable and must be formulated carefully in order to be effective.\u201d\n\nBut believers like True Nature Botanicals\u2019 Ms. Peterson are undeterred.\nThe devotion to hats and rash guards, the careful selection of sunscreen and thorough application and reapplication every 90 minutes is at best tedious, and when children are involved, the process can be truly demoralizing.\n", "question": "Does the story commit disease-mongering?", "explanation": "The article, which does not cite the toll caused by skin cancer, does not overplay the dangers of sun exposure, but it misses an opportunity to shed light on its growing incidence. The reference to Ms. Peterson \u201csurviving melanoma\u201d could be seen as overly dramatic, since most cases are detected early and treated by simply cutting out the skin growth in a doctor\u2019s office.", "answer": 1}, {"article": "LONDON (Reuters) - Scientists in Britain have developed a type of HIV test using a USB stick that can give a fast and highly accurate reading of how much virus is in a patient\u2019s blood.\nBut in some cases the drugs stop working - sometimes because virus has developed resistance to them - and the first sign of that would be a rise in a patient\u2019s so-called \u201cviral load\u201d.\nAt the moment, testing often requires costly and complex equipment that can take a couple of days to produce a result,\u201d said Graham Cooke, who co-led the research from the Imperial\u2019s department of medicine.\nPublished in the journal Scientific Reports, results showed the stick test was 95 percent accurate over 991 blood samples, and the average time to produce a reading was 20.8 minutes.\nSome 36 million people worldwide are infected with the human deficiency virus (HIV) that causes AIDS, and the majority of them live in sub-Saharan Africa.\n", "question": "Does the story commit disease-mongering?", "explanation": "We didn\u2019t find any outlandish descriptions of HIV or AIDS.", "answer": 1}, {"article": "Antioxidants are found in different levels in fruits and vegetables, such as blueberries or broccoli.\nThey also made fewer trips to the hospital.\nInvestigators have yet to show this.\u201d\nBrosius was skeptical of the benefits, although he said the juice was unlikely to cause harm.\nNEW YORK (Reuters Health) - There may be a seed of truth amidst the many health claims for pomegranate juice, researchers from Israel said Thursday, at least for kidney patients on dialysis.\n", "question": "Does the story commit disease-mongering?", "explanation": "There was no disease mongering in the story.", "answer": 1}, {"article": "Immunotherapy moves to the front lines in fight against lung cancer\n\nThe cancer death rate has dropped again.\nThe studies simultaneously were published by the New England Journal of Medicine on a day that some experts called the \u201cSuper Bowl of lung cancer immunotherapy.\u201d\n\nThe reports underscore the increasingly important first-line role that immunotherapy, which unleashes the immune system to destroy cancer cells, is taking against the deadliest cancer.\nH. Jack West, an oncologist at Swedish Medical Center in Seattle, said, \u201cIt is literally practice-changing \u2014 immediately.\u201d\n\nRoy Herbst, an oncologist at Yale Cancer Center said that most lung cancer patients now will be offered immunotherapy in some form much earlier than before.\nThe trial that grabbed much of the spotlight Monday is a randomized effectiveness study that involved more than 600 untreated patients with advanced nonsquamous non-small cell lung cancer \u2014 a common type of the disease.\nBut the disease is so lethal that many patients don\u2019t survive long enough to try second- or third-line treatments, so researchers are trying to develop and use more effective approaches earlier.\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease-mongering here. The story states that lung cancer is the \u201csecond-most-common malignancy in the United States, after breast cancer. The American Cancer Society estimates that 234,000 people will be diagnosed with the disease this year, and 154,050 will die of it.\u201d\nHowever, the story could have explained that about 140,000 of these patients have nonsquamous non-small cell lung cancer, the condition that is treatable with Keytruda.", "answer": 1}, {"article": "\"Dark chocolate may be a pleasant and effective way of delivering important dietary components that can provide health benefits to the ever increasing numbers of people at increased risk of cardiovascular disease,\" says researcher Christopher M. Reid, PhD, professor of cardiovascular epidemiology and preventive medicine at Monash University in Australia.\nMaybe, according to a new study from Australia.\nThey found it would be.\nThey did not study actual people eating actual chocolate.\nThe study is published in the journal BMJ.\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease-mongering of heart attack and stroke.", "answer": 1}, {"article": "And if I can be saved, so can other people.\u201d\n\nThe study results were unveiled Thursday in advance of a major cancer conference next month.\nLu said the study isn't large enough to justify recommending yet.\nThere were only a few false positives.\nThree of the eight turned out to have benign tumors.\nThere is no such screening tool currently in use.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story does not hype the seriousness or prevalence of ovarian cancer. It is a devastating diagnosis.", "answer": 1}, {"article": "Injections of botulinum toxin, best known as a wrinkle treatment, are now being used increasingly to prevent chronic migraine sufferers. Scientific data are mixed, but two large recent studies show Botox can reduce the number of headache days in chronic sufferers.\n\nMigraine headache is a debilitating neurological condition that manifests itself as an intense throbbing pain on one or both sides of the head, according to the Migraine Research Foundation, a New York nonprofit. Some 14 million people experience migraine attacks...", "question": "Does the story commit disease-mongering?", "explanation": "The article did not engage in explicit disease-mongering. Chronic migraines are painful, disabling and potentially debilitating.\nHowever, the article over-emphasizes the views of authors who have relationships with the developer of Botox. Careful reading of the study suggests that the study subjects had a special and severe type of migraine\u2014and may not be representative of the larger population with chronic migraines. The results of the study may not apply to many individuals with chronic migraines.\nOn the plus side, the story was careful to emphasize that the treatment may not be beneficial for those with less frequent and less severe migraines.", "answer": 1}, {"article": "Traumatic injuries to the head, often from car accidents, tend to sever brain cell connections and leave many neurons intact.\nWithout this context, Dr. Fins said, the imaging tests could create some confusion, because like any medical tests they may occasionally go wrong, misidentifying patients as exhibiting consciousness or lacking it.\nDr. Nicholas Schiff, a neuroscientist at Weill Cornell Medical College in New York, said that the study provided \u201cknock-down, drag-out\u201d evidence for mental awareness, but that it was not clear \u201cwhether we\u2019ll see this in one out of 100 vegetative patients, or one out of 1,000, or ever again.\u201d\n\nIn a more recent exam, more than 11 months after her injury, the patient exhibited a sign of responsiveness: she tracked with her eyes a small mirror, as it was moved slowly to her right, and could fixate on objects for more than five seconds, said Dr. Steven Laureys, a neurologist at the University of Li\u00e8ge and an author of the study.\nAbout 50 percent of people with such injuries recover some awareness in the first year after the injury, studies find; very few do so afterward.\nThis means by definition that the young woman has transitioned from an unresponsive, vegetative state to a sometimes responsive condition known as a minimally conscious state, Dr. Laureys said in an interview.\n", "question": "Does the story commit disease-mongering?", "explanation": "By accurately describing the woman\u2019s mental state, the story avoids disease mongering. The article also accurately states that the observed finding was in a single patient. It is unclear how common it would be when applied more broadly to patients with severe cognitive impairment.", "answer": 1}, {"article": "Soy may keep breast cancer from coming back\nMost of the women in the study had never been smokers, and there\u2019s a lot of evidence to suggest that lung cancer is a different disease in smokers versus non-smokers.\nThe findings, published in the Journal of Clinical Oncology, lends support to the idea that adding soy foods to the diet can help people in multiple ways, says Dr. Jyoti Patel, a lung cancer specialist at Northwestern University in Chicago, who was not involved in the study.\nFor the study, Gong Yang and colleagues at Vanderbilt University Medical Center, Shanghai Cancer Institute, and the National Cancer Institute looked at data from a large study of Chinese women called the Shanghai Women\u2019s Health Study.\n\u201cAlthough the risks are probably different for American women for developing lung cancer, I do think it is a call to action for more research about how we develop lung cancer,\u201d Patel said.\n", "question": "Does the story commit disease-mongering?", "explanation": "This was a tricky call. The story calls lung cancer \u201cthe No. 1 cancer killer across the world,\u201d and gives various lung cancer statistics\u00a0describing a huge toll\u00a0in the United States. The story qualifies these statements by noting that the Chinese women in this study were overwhelmingly non-smokers, and that lung cancer in non-smokers is probably a different disease than in smokers. But it never completely\u00a0closes the loop on what this all means for\u00a0women in the USA and other Western countries who are trying to make sense of these findings.\u00a0Smoking accounts for some 87% of lung cancer deaths in the\u00a0USA, according to the American Cancer Society, and the rate of lung cancer in\u00a0nonsmoking women is much lower in the USA than it is in China. The upshot is that the findings probably have much less relevance\u00a0for women in USA than they do for Chinese women. The story should\u00a0have stated this more clearly.", "answer": 0}, {"article": "Feb. 1, 2012 -- A new drug appears to be effective for shrinking uterine fibroids and controlling the heavy menstrual bleeding they often cause, according to new research from Europe.\nIf trials now under way in the U.S. prove positive, New Jersey-based Watson Pharmaceuticals Inc. and Swiss-based PregLem hope to market ulipristal acetate as a fibroid treatment under the trade name Esmya, says Watson spokesman Charlie Mayr.\nIn one study, the drug ulipristal acetate proved to be much more effective than a placebo for shrinking the non-malignant uterine tumors.\nBoth studies appear in the Feb. 2 issue of The New England Journal of Medicine.\nUlipristal acetate is the active chemical in the emergency contraceptive sold in the U.S. as Ella, but the daily doses taken by the fibroid patients in the studies were much smaller than those in the contraceptive.\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease mongering. This story provided a few more facts than the AP story and made it clear why these findings may be hugely important for women with fibroids. It said, \u201cUterine fibroids are the most common indication for the close to 600,000 hysterectomies performed each year in the U.S. About 1 in 4 women in their childbearing years have symptoms related to fibroids, such as heavy periods and related iron deficiency, abdominal pain, and fertility problems, according to figures from the National Institutes of Health.\u201d", "answer": 1}, {"article": "And for the test to be useful, \"you've got to find cancer that's going to otherwise be lethal, and not cancer that would otherwise be destined to do nothing,\" Prasad says.\nBut these methods alone don't give reliable results.\nOf course, the ultimate goal of this test is to find cancer in people who haven't already been diagnosed.\nBut they have a long way to go.\nAnd that percentage could well be lower than the 70 percent average.\n", "question": "Does the story commit disease-mongering?", "explanation": "There is no disease mongering in this story.", "answer": 1}, {"article": "About 35% of U.S. adults take calcium supplements, alone or in multivitamins, according to a recent report in the medical journal JAMA.\nTeen girls, who are in crucial bone-building years, often have diets that fall short of their needs, 1,300 mg a day, Wallace says.\nLarger doses are poorly absorbed and rarely needed, he says.\nSome people do need supplements.\nThe first is that most people don\u2019t need them, Rosen says.\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease mongering here. If anything, this is quite the opposite: giving readers more information in order to help them make informed decisions.", "answer": 1}, {"article": "\"It's really mild,\" said Bardwell.\nBecause new drugs can only be tested on top of existing therapy, introducing potentially better drugs is difficult.\nIf the experiment proves successful, it would provide an entirely different approach to heart failure, a chronic, progressive disease that affects nearly 6 million Americans.\nThere is considerable data showing connections between the brain, nervous system and heart, said Torre, but until now, no one has attempted to take advantage of the relationship therapeutically.\nA typical heart failure patient is on seven such drugs, which Torre characterized as \"the limit.\"\n", "question": "Does the story commit disease-mongering?", "explanation": "The patient profiled in the story is clearly in the most advanced stage of heart failure and may have\u00a0a dire outlook, but there are many effective and life prolonging therapies for earlier stages and not all patients reach his stage.\u00a0In addition, it is misleading to suggest that most\u00a0patients end up on 7 drugs that are ineffective;\u00a0there are many lifestyle, dietary, and drug treatments that are known to be effective for heart failure. This patient anecdote \u2013 coupled with phrases such as \"prognosis is grave\" and \"usually ultimately fatal\" \u2013 may mislead readers. ", "answer": 0}, {"article": ".\nPilot study published in the Journal of the American Osteopathic Association finds targeted pressure device significantly increased sleep for those with moderate to severe symptoms\n\nAuthors from Lake Erie Research Institute in Pennsylvania report an adjustable foot wrap caused to treat restless legs syndrome (RLS) is 1.4 times more effective than the standard pharmaceutical treatment.\nClinical Global Impression responses indicated significantly greater improvement with the RLS device (90 percent) compared with ropinirole (63 percent), the current standard dopamine therapy for RLS.\nPatients using the RLS device also reported an 82 percent decrease in sleep loss.\nAccording to the National Institute of Health, RLS may affect as many as 10 percent of the U.S. population, with more than nine million experiencing moderate to severe symptoms.\n", "question": "Does the news release commit disease-mongering?", "explanation": "The release quotes the National Institute [sic] of Health as saying more than nine million people in the US experience moderate to severe restless leg symptoms similar to those of the participants in this trial. However, it would have been helpful for the release to also point out that the NIH says 70 to 80 percent of people with RLS have a milder form, and that people who report leg movements during sleep have different conditions, such as \u201cperiodic limb movement of sleep\u201d (PLMS).", "answer": 1}, {"article": "EEGs measure brain electrical activity through electrodes attached to the scalp.\n\"One of the difficulties with a disorder like autism is that it's very heterogenous.\nA very high-functioning person with autism might not be so different from a so-called 'normal' person who is quirky.\nWe know early intervention is extremely important.\nRight now, for a lot of children, that means 3 years old.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story takes a fairly straightforward approach at first, but it gradual builds up a head of steam before blowing its top when lead author Dr. William Bosl says, \u201cMy hope is we would have a simple way of measuring brain activity in every child and see the patterns emerging that might track autism characteristics. \u2026 That would be tremendously useful. We know early intervention is extremely important. Right now, for a lot of children, that means 3 years old. What we don\u2019t know yet is if you can intervene at 9 or 12 months and how effective that could be.\u201d Every single child should be hooked up to an EEG? Based on a study that looked at 79 kids, only 46 of whom were in the high risk pool? This seems like an overstatement that should have been challenged in the story. Unchallenged, it contributes to an atmosphere of fear and paranoia around autism spectrum disorders, very real and serious conditions that have led to some very unfortunate hysteria in some quarters.", "answer": 0}, {"article": "In acute kidney injury, the kidneys shut down, causing fluids and waste products to build up in the body.\nDr. Bonventre wrote that the study had \"a predominance of male patients,\" so there is a question of whether its results can be applied to female patients.\nThroughout the study, patients remained in intensive or less intensive therapy, although as their clinical conditions changed, they could change forms of therapy, Dr. Palevsky said.\n... We still have a long way to go in treating acute kidney injury.\"\nThe VA reports the condition has a 50 percent to 80 percent death rate.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story did not engage in overt disease mongering.", "answer": 1}, {"article": "It's crazy enough to laugh off.\n\"These results will help us get closer to using these compounds more effectively in foods or supplements to maintain normal blood glucose control and potentially even delay or prevent the onset of type-2 diabetes,\" said study co-author Andrew Neilson, assistant professor of food science at Virginia Tech.\nBut rather than stocking up on the sugar-rich chocolate bars at the checkout line, researchers believe the starting point is to look for ways to take the compound out of cocoa, make more of it and then use it as a potential treatment for current diabetes patients.\nBut here's the thing: BYU researchers have discovered certain compounds found in cocoa can actually help your body release more insulin and respond to increased blood glucose better.\nThey found that by adding it to the high-fat diet, the compound would decrease the level of obesity in the animals and would increase their ability to deal with increased blood glucose levels.\n", "question": "Does the news release commit disease-mongering?", "explanation": "Diabetes is a widespread and serious health threat. However, the careless wording of this news release (and the skewed news coverage it encourages) could well mislead people who do not have diabetes to use the headlines as an excuse to eat more chocolate. The implication of the news release is that this compound can be given to people at risk of developing type 2 diabetes with the goal of delaying their \u201cdescent\u201d into overt diabetes, but this could lead to over-treatment of mild diabetes.", "answer": 1}, {"article": "While some previous research has found acupuncture for lazy eye effective, the researchers couldn't find a study that directly compared acupuncture with conventional treatments such as patching.\nThe study, conducted in China, is published in the Archives of Ophthalmology.\nThey assigned 43 children to the acupuncture group, and they received five treatments a week.\nThe children were instructed to do an hour per day of near-vision activities such as homework or computer work.\nU.S. experts familiar with the study call it interesting but say the treatment needs more study and wonder if it would catch on in the U.S.\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease-mongering here.", "answer": 1}, {"article": "Please use our search feature and update your bookmarks. Thank you!", "question": "Does the news release commit disease-mongering?", "explanation": "No fear mongering here.", "answer": 1}, {"article": "In the meantime, screenings continue.\nSince the study began about a year ago, 500 local teens have been screened and 26 diagnosed with heart abnormalities.\nIn the most complete test of its kind, the institute is using both an electrocardiogram and limited echocardiogram to see the rhythm and structure of the heart.\nFewer Italian athletes died after the testing began, but the tests also had a relatively high rate of falsely reporting medical problems.\nWhat (abnormality) is going to contribute to the overall health versus something that just looks funny?\n", "question": "Does the story commit disease-mongering?", "explanation": "Although the health risks of participating in sports (even after detection of some sort of unusual heart feature) are a matter of intense debate among medical experts, this story presents any abnormality as a clear and present danger. There is no evidence presented to rule out a repeat of the Italian experience reported in the story that \u201cled to unnecessary physical restrictions of athletes,\u201d and yet readers are told that the teens who didn\u2019t pass this test had health conditions that put them at imminent risk of death. Based on the statistics reported in this story, if national screening were adopted about 100,000 high students each year would be labeled has having a heart abnormality requiring lifelong monitoring.", "answer": 0}, {"article": "For example, psoriatic arthritis manifests most often in the lower extremities and is associated with the autoimmune skin condition called psoriasis, in which raised red, scaly patches appear on the skin.\nAlthough the ultimate cause of the disease remains unknown, there was a good clinical rationale for hoping it might be responsive to ixekizumab.\nLilly has filed for approval of the drug by the U.S. Food and Drug Administration.\nThe drug, an injectable monoclonal antibody, is already commercially available for the treatment of psoriasis, for which it has been remarkably effective, said Genovese.\nThose getting the drug every two weeks didn\u2019t do any better and were slightly more prone to side effects, such as a mild reaction at the injection site.\n", "question": "Does the news release commit disease-mongering?", "explanation": "There is no disease mongering. The release provides strong context on the condition as well as how the drug is believed to work.", "answer": 1}, {"article": "Guyuron, chair of plastic surgery at University Hospitals Case Medical Center in Cleveland, went on to identify four common \"trigger sites\" and publish studies showing that, in selected patients, surgical decompression of nerves in one or more of these sites provides lasting migraine relief. He has also taught 250 plastic surgeons around the world (none in the Philadelphia area) to perform the outpatient operation, which costs an average of $10,000 and is not covered by many insurers.", "question": "Does the story commit disease-mongering?", "explanation": "The numbers are there \u2013 but disconnected \u2013 in the story.\nIn one place we learn that there are \u201c36 million hapless Americans who suffer from migraines.\u201d\nIn another we learn that the FDA approved Botox for chronic migraines that afflict \u201c3 percent of migraineurs.\u201d\nIn another place, a neurologist says the approach may be \u201chelpful to a subgroup of migraineurs.\u201d\nWe wish the story had made it clear \u2013 in one place \u2013 that not all migraines are the same and not all might be candidates for an approach like this.\n\u00a0", "answer": 1}, {"article": "\u201cThe number of dementia cases could drop by half.\u201d\n\nNov. 20: MRI scan may predict which people will develop Alzheimer's disease\n\nLambracht-Washington said the study marks major progress toward a safe and effective vaccine.\nThe number could double by 2050.\n\u201cIf the onset of the disease could be delayed by even five years, that would be enormous for the patients and their families,\u201d Lambracht-Washington said in a statement.\nThe vaccine is one of several promising treatments aimed at reducing the buildup of those substances before they become deadly plaques and tangles in the brain.\nDoris Lambracht-Washington, a professor of neurology and neurotherapeutics at the University of Texas Southwestern Medical Center, said researchers believe the vaccine could extend lives by preventing the disease from developing.\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease-mongering here.", "answer": 1}, {"article": "FDA approves breakthrough cholesterol drug, but only for certain high-risk patients\n\nOvereating may be caused by a hormone deficiency, scientists say\n\nCDC report: Lyme disease is spreading to new territories\n\nResearchers retract study claiming marriages fail more often when wife falls ill\nPaul Workman, professor and chief executive of the Institute of Cancer Research in London, said in a statement accompanying the publication of the journal article that \"the evidence on aromatase inhibitors has been accumulating for well over a decade, but it has taken this huge and complex study to make sense of all the data, and provide a firm basis for clinical guidelines.\u201d\n\n\"It tends to be the discovery of new treatments that grabs the headlines, but it is just as important to maximize the benefit patients get from existing treatments through major, practice-changing studies like this,\" Workman said.\n\u201cThe drugs are complementary, because the main side effect of aromatase inhibitors is an increase in bone loss and fractures, while bisphosphonates reduce bone loss and fractures as well as improving survival,\" he said.\nIf this had not happened, \"the benefit of aromatase inhibitors over tamoxifen would probably have been somewhat greater,\" they surmised.\nThe results were part of the Early Breast Cancer Trialists' Collaborative Group, a collaboration based at the University of Oxford, that collects and analyzes information about randomized clinical trials every few years.\n", "question": "Does the story commit disease-mongering?", "explanation": "There is no disease mongering in this article. Although, as noted above, we think there\u2019s some\u00a0\u201ctreatment mongering\u201d going on both the headline and closing quote from a researcher who says,\u00a0\u201cThe drugs are complementary, because the main side effect of aromatase inhibitors is an increase in bone loss and fractures, while bisphosphonates reduce bone loss and fractures as well as improving survival.\u201d These two drugs are commonly prescribed together but the study does not address their use in combination. If the story is going to focus on an issue that wasn\u2019t even addressed in the studies being reported on, we think it\u2019s essential to include a statement from an independent expert about that suggestion.", "answer": 1}, {"article": "The bone cells don't have the ability to lay down new bone.\"\nThe editorial pointed out, however, that Forteo should not be used in patients whose cancer has already spread to the bone, as it might prompt even more spread.\nAccording to an editorial accompanying the study, this complication occurs in about 5 percent of cancer patients who are taking a high-dose bisphosphonate (Zometa or Aredia) to control or prevent spread of malignancy to the bone.\nBut the two papers in the Oct. 16 online issue of the New England Journal of Medicine report success with teriparatide (Forteo) in rebuilding bone.\nExperts have already noticed an uptick in the incidence of this rare but devastating condition in patients using bisphosphonates.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story does not engage in disease-mongering. While raising the connection between bisphosphonates and bone loss in the jaw, the article is careful to add qualifiers like \u201cheavy use\u201d and several mentions of \u201crare.\u201d It states that the incidence is increasing in patients receiving bisphosphonates for osteoporosis, but it\u2019s much rarer than the 5% incidence in patients receiving bisphosphonates during cancer treatment. The story also distinguishes between low-dose and high-dose brands of bisphosphonates.", "answer": 1}, {"article": "Rates are rising, in part because tanning became fashionable.\n\u201cIt's difficult to know at what point you call it a cure.\nCarter, for example, was only diagnosed once the tumors had spread to his brain, last fall.\nHe says there\u2019s no trace of his cancer now.\nIt was bad enough for 8 percent of patients that they stopped taking it.\n", "question": "Does the story commit disease-mongering?", "explanation": "We didn\u2019t see any gratuitous or frightening description of melanoma\u2019s many symptoms or treatment side effects.", "answer": 1}, {"article": "Shift workers with chronic sleep deprivation also face an increased risk of accidents.\n\u201cSleep deprivation makes this worse of course, and together with the clock, this conspires to impair our ability to sustain attention to task (e.g., driving), and avoid distraction, and react quickly to external stimuli like traffic lights, brake lights in front of you, road signs, etc,\u201d Mistlberger added by email.\nFor the current study, researchers wanted to see if bright light might help reduce driving impairments related to sleep deprivation.\nMore research is needed on the potential of bright light therapy to make exhausted drivers safer, said Dr. Donald Redelmeier, a researcher at the University of Toronto who wasn\u2019t involved in the study.\nAfter sleep deprivation in the lab, five people exposed to dim light therapy got in car accidents during the driving simulations.\n", "question": "Does the story commit disease-mongering?", "explanation": "Sleepy drivers are dangerous drivers, so this study focuses on a real risk.", "answer": 1}, {"article": "At the end of the study, the group of volunteers who had used the dapivirine ring had 27% fewer HIV infections than a control group who had a placebo ring with no drug, the study found.\n\u201cThere is absolute reason to celebrate.\n\u201cFor some women, a pill every day might work really well.\n\u201cIf used perfectly, how much HIV protection could there be?\n\u201cWe obviously always want higher numbers.\n", "question": "Does the story commit disease-mongering?", "explanation": "There was no disease mongering.", "answer": 1}, {"article": "With knee-replacement surgery on the rise, more patients with two bad knees are opting for a controversial procedure that replaces both at the same time.\n\nSimultaneous bilateral knee replacement, as the surgery is known, is a subject of debate among orthopedic surgeons, with conflicting evidence about the risks and benefits. Proponents say it eliminates the need for a second hospital stay and grueling rehabilitation period, reduces time spent under anesthesia and costs less.", "question": "Does the story commit disease-mongering?", "explanation": "No disease mongering here.", "answer": 1}, {"article": "Past studies have looked at how women classified as low, intermediate or high risk by the test have fared.\nResults on these groups are not yet ready \u2014 the study is continuing.\nThe usual treatment is surgery followed by years of a hormone-blocking drug.\n\u2018\u2018I was convinced that there was no indication for chemotherapy.\n\u2018\u2018The future is bright\u2019\u2019 for gene tests to more precisely guide treatment, he said.\n", "question": "Does the story commit disease-mongering?", "explanation": "There is no disease mongering in this article.", "answer": 1}, {"article": "However, only the mice that consumed black tea extract had an increase in a type of bacteria called Pseudobutyrivibrio, which could help explain the difference between how black tea and green tea change energy metabolism.\nThe research is published in the European Journal of Nutrition.\nThe study was funded by the National Institutes of Health and the UCLA Center for Human Nutrition.\n\"Our new findings suggest that black tea, through a specific mechanism through the gut microbiome, may also contribute to good health and weight loss in humans.\"\nThe new findings show that black tea polyphenols, which are too large to be absorbed in the small intestine, stimulate the growth of gut bacterium and the formation of short-chain fatty acids, a type of bacterial metabolites that has been shown to alter the energy metabolism in the liver.\n", "question": "Does the news release commit disease-mongering?", "explanation": "There is no disease mongering here.", "answer": 1}, {"article": "The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center -- which are recognized as one of the nation's top \"Honor Roll\" hospitals by U.S. News & World Report -- Chester County Hospital; Lancaster General Health; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751.\n\"Based on the literature and our results, women with dense breast tissue who desire supplemental screening, these results suggest that AB-MR may be a better option than other supplemental screening tests such as whole breast ultrasound.\nTo put this in perspective, the cancer detection rate of mammography is roughly 4 cancers in 1,000 women who have a mammogram.\n\"Having dense breast tissue makes it more difficult to detect a cancer on a mammogram,\" said the study's lead author, Susan Weinstein, MD, an associate professor of Radiology and the director of breast MRI at Penn Medicine.\nDigital tomosynthesis (DBT), or 3D mammography, does slightly better, detecting approximately 25 percent more cancers, or roughly 5 cancers in 1,000 women screened.\n", "question": "Does the news release commit disease-mongering?", "explanation": "The release veers into disease mongering when it drops in the comment that \u201cOne in eight women in the United States will develop breast cancer at some point during their life.\u201d That\u2019s a jarring statistic that rarely fails to get attention. But to add perspective, consider what the National Cancer Institute notes about a woman\u2019s lifetime risk of developing breast cancer: \u201ca woman born today has about a 1 in 8 chance of being diagnosed with breast cancer at some time during her life. On the other hand, the chance that she will never have breast cancer is 87.6 percent, or about 7 in 8.\u201d [Emphasis added.]\nAnd as noted above, it would have been helpful if the release had stated how many cancers versus DCIS were found through the abbreviated MRI.\u00a0  ", "answer": 0}, {"article": "Merck filed in February for FDA approval of Keytruda for both initial and secondary treatment of advanced urothelial cancer, the most common type of bladder cancer.\nMerck announced in October that the second-line bladder cancer study met its main goal and was stopped early.\nThe Merck drug is awaiting U.S. Food and Drug Administration approval, but Tecentriq was approved by the agency last year, contingent on verification of its clinical benefit.\nAccording to the FDA approval letter, the company has until December to submit the full trial data to the agency.\nThe data, to be presented next month at a meeting of the American Society of Clinical Oncology, follow last week\u2019s announcement that rival drug Tecentriq, from Roche Holding AG, did not improve survival when used as a second-line treatment for bladder cancer in a trial.\n", "question": "Does the story commit disease-mongering?", "explanation": "This is a barely passing satisfactory. Some numbers on how common advanced bladder cancer is, and its mortality rate for standard treatment, would have been useful.", "answer": 1}, {"article": "\"I would say that hearing better kind of completes your personality, and I think Ethan became a complete personality once his hearing came online.\u201d\n\nAfter witnessing Priddy's miraculous results, Naberhaus was inspired to shrug off his image as the hard-of-hearing teacher and get a cochlear implant.\nThese things are music to his ears.\n'\u201d he said.\nHe has never heard the world better.\nJust two years ago, he feared he might not hear anything again.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story describes a real problem\u2014deafness\u2013without overselling or exaggerating its importance.", "answer": 1}, {"article": "Cancer cells remain elusive and tough to locate, but a new crop of nuclear-imaging tests promises to lead to more accurate prognosis and treatment.\n\nThe tests use imaging agents that combine radioactive isotopes with targeted molecules that can spot cancer at the cellular level. The ability to accurately locate the cancers helps physicians make better and earlier diagnoses\u2014and may eventually make possible targeted nuclear-medicine therapies that identify and kill cancer cells, but not the surrounding healthy cells.", "question": "Does the story commit disease-mongering?", "explanation": "No disease mongering.", "answer": 1}, {"article": "But how?\nAs an alternative, there's a relatively new product called Fernblock, which claims to protect the skin internally by systemically inhibiting the absorption of ultraviolet rays.\nWe've long assumed sunscreens will do the trick, but then came reports that the vitamin-A compound (retinyl palmitate) integral to many of them could actually be making us more melanoma-prone.\nA cautionary note:The damning evidence against vitamin A, which has long been used as a skin-cancer treatment, came from experiments done on mice, which have a far higher susceptibility to skin cancers than humans.\nAnd though dermatologists who have experience with Fernblock think it offers a measure of protection, even the manufacturer warns it won't suffice alone.\n", "question": "Does the story commit disease-mongering?", "explanation": "The article does not hype or monger skin cancer or skin aging from sun rays.", "answer": 1}, {"article": "Their median age was 63.\nTwo small prospective studies have suggested no survival difference among women with Stage 4 breast cancer who have surgery and those who don't, he said.\nStill there may be reasons to remove the cancer in the breast.\nA large, randomized, prospective study currently being conducted by the Eastern Clinical Oncology Group should produce the most reliable data on the subject to date, he said.\nBut with better therapies to control the cancer systemically and improved imaging that finds ever-smaller deposits of cancer in other parts of the body, it may be time to see whether surgery also can help increase the length of survival times, they said.\n", "question": "Does the story commit disease-mongering?", "explanation": "The article does not engage in disease mongering, although it could have been helpful to learn more about the prevalence of breast cancer in the US.", "answer": 1}, {"article": "Enter EllaOne, a member of a new class of drugs called selective progesterone receptor modulators.\nAs many as 80% of all women have uterine fibroids (noncancerous growths in the uterus), according to the nonprofit National Uterine Fibroids Foundation.\nSurgery is often the only way to treat painful, bleeding fibroids, but surgery too can sometimes compromise fertility.\nFibroids may cause severe abdominal pain, heavy bleeding, and interfere with fertility in some women.\nAlthough EllaOne is not available in the U.S., an FDA advisory panel recently voted that it should be.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story verges on disease mongering by exaggerating the seriousness of fibroids. While it is true that up to 80% of women may have fibroids, only about 20% of women will have symptoms that are bothersome enough that they would seek treatment. Fibroids in of themselves are benign and are not problematic unless they cause symptoms and treatment should only be initiated if a woman is bothered by them. Symptoms of fibroids also most often go away after menopause. However, this story leaves the impression that all women with fibroids should be treated.", "answer": 0}, {"article": "Among the women who initially had no heart disease and did not take any dietary supplements, 3.4 percent had heart attacks, compared to 2.6 percent of the women who took multivitamins plus other supplements; this translated to a 27 percent lower heart attack risk with vitamins.\n\u201cIt is very important to keep in mind that multivitamin users tend be \u2018healthier\u2019 in general.\nShe concluded: \u201cThe question of whether multivitamins are good for you still remains!\u201d\nThe results don\u2019t settle the question of whether it\u2019s actually the vitamin pills that are protective, Rautiainen told Reuters Health via e-mail.\nSimilar studies have been done in men, with some confirming the current findings and others contradicting them, Rautiainen said.\n", "question": "Does the story commit disease-mongering?", "explanation": "\u00a0The story did not engage in overt disease mongering.", "answer": 1}, {"article": "\u201cIt\u2019s one and done,\u201d he said.\nAn estimated 10 million people in the United States suffer from the condition, according to the International Essential Tremor Foundation.\nHe added that since these patients were only followed for a year, there isn\u2019t enough data available yet to determine the long-term efficacy of the treatment.\nIn an ongoing clinical trial at 11 medical centers globally, researchers are using ultrasound waves to treat the source of essential tremor in the brain.\nDoctors usually treat essential tremor with medication, but the drugs don\u2019t work well for all patients.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story cites a figure from the International Essential Tremor Foundation, an advocacy group, that an estimated 10 million people in the United States suffer from the condition. However, a 2014 analysis of existing research put the number of cases at around 7 million as of 2012, or about 2.2% of the U.S. population. While this may not qualify as disease mongering, the story could have pointed out that the exact number of cases isn\u2019t clear. Also, the story should have noted that not all people with essential tremor have symptoms severe enough to require treatment.", "answer": 1}, {"article": "After three months, 16 percent of the women who were enrolled in both Text4baby and Quit4baby had quit compared with just 11 percent of women getting just Text4baby.\nThe more intensive intervention did seem to help two subgroups quit smoking at least in the short run, Abroms says.\n\"The study's findings suggest a potential new quitting strategy, especially for those later in their pregnancies and older pregnant women.\"\nVery little help is provided to pregnant smokers who want to quit so the study's findings are important, especially if the strategy can be adjusted to be more effective, Abroms says.\nThe research was supported by the National Institute on Drug Abuse, part of the National Institutes of Health.\n", "question": "Does the news release commit disease-mongering?", "explanation": "No disease mongering here. Risks to fetuses from smoking are real.", "answer": 1}, {"article": "Allergan Inc. said that two large human tests of its Botox drug, best known for smoothing wrinkles, showed that periodic injections prevent headaches in adults who suffer from chronic migraines.\n\nEven though details of the study weren't released, the announcement, which surprised many physicians and investors, sent Allergan's shares soaring 11%, or $5.95, to $60.53 at 4 p.m. in New York Stock Exchange composite trading. Botox has been used to treat severe headaches for many years, but some researchers have long been skeptical...", "question": "Does the story commit disease-mongering?", "explanation": "The story does not exagerrate the seriousness or prevalence of chronic migraines and is clear to repeatedly mention that chronic, severe\u00a0migraines are the indication in question, not everyday garden-variety headaches.", "answer": 1}, {"article": "\u201cWe were pretty surprised by the strong association with objective things like the 49 percent reduction,\u201d he said.\nAfter adjusting for age, diabetes, hypertension and other factors, men who took a daily aspirin or another Nsaid reduced their risk of moderate or severe urinary symptoms by 27 percent, and their risk of an enlarged prostate by 49 percent.\nTaking aspirin every day may lower the risk for prostate enlargement, a new study has found.\nOther nonsteroidal anti-inflammatory drugs, or Nsaids, like naproxen (Aleve) or ibuprofen (Advil or Motrin), have the same effect.\nMoreover, they had a 48 percent reduced risk of having an elevated level of prostate-specific antigen, or P.S.A., the protein measured in a common blood test for prostate cancer.\n", "question": "Does the story commit disease-mongering?", "explanation": "The article provides very limited information about prostate enlargement, known as benign prostatic hyperplasia or BPH. Of note, this condition is not cancerous or life-threatening. Also, the article mentions a possible benefit being lower PSA levels, noting that this is a common blood test for prostate cancer. This implies that using aspirin or other similar drugs for BPH can also reduce a man\u2019s chance of prostate cancer, for which there is no evidence. In fact, elevated PSA levels can often be due to conditions like BPH and not due to cancer; with less enlargement of the prostate, it\u2019s not unexpected to also find lower PSA levels. The broad use of the term \u201curological problems\u201d also seems to overstate what the study was about, evaluating a specific condition (BPH). ", "answer": 0}, {"article": "\u25a0 A woman who freezes eggs rather than embryos avoids potential custody problems if she and her partner split up.\nShe owns her eggs, no question.\nFreezing eggs now is no guarantee of a baby later.\nCheck out more than one clinic and make sure you know what it defines as a \u201csuccess\u2019\u2019 \u2014 a viable transferring of an egg leading to a baby, or just a safely thawed egg.\nIf you decide to try egg freezing, don\u2019t wait too long.\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease mongering in the story. ", "answer": 1}, {"article": "\"They say, 'Oh my God, this has changed my life.\nSeldom has one pill raised such controversy among medical professionals.\n(CNN) A new review of the \"little pink pill\" for women with low sexual desire says the drug doesn't work very well -- but some doctors and patients who've been using the treatment disagree.\nSome doctors and patients who've been using Addyi say the drug has been helpful.\nThere are no other FDA-approved treatments for women suffering from low sexual desire.\n", "question": "Does the story commit disease-mongering?", "explanation": "There are many who would say that HSDD is a construction by the pharmaceutical industry keen to capitalize off women\u2019s sexual health. \u00a0Whether you agree with that perspective or not, if you are writing about a controversial condition, you must include some coverage of that controversy, otherwise you are at risk of further medicalizing and hyping a condition that maybe doesn\u2019t, in most cases, warrant a medical treatment approach.", "answer": 0}, {"article": "Chinese herbal medicine increased IELT by about two minutes, Ayurvedic herbal medicine increased IELT by nearly a minute and topical cream increased IELT by more than eight minutes.\n\u201cTo our knowledge, this is the first systematic review to assess complementary and alternative medicine for premature ejaculation.\u201d\n\nAccording to the International Society for Sexual Medicine, premature ejaculation can be a lifelong problem, and this primary form of the problem is usually defined as ejaculation happening within one minute of initiating vaginal intercourse every time a man has ever had sex.\n\u201cWe need treatments to address it, and it should be treated with equal seriousness as erectile dysfunction.\u201d\n\nThe prevalence of premature ejaculation is difficult to measure because of the differing definitions of the problem and some men\u2019s reluctance to report it.\nThe improvements were small, and the studies were of varying quality, but preliminary evidence suggests that acupuncture, Chinese herbal medicine, Ayurvedic herbal medicine and a Korean topical cream may all have desirable effects, researchers conclude in the journal Sexual Medicine.\nSome studies suggest that between 20 and 30 percent of men report early ejaculation concerns, but the International Society for Sexual Medicine estimates that about 4 percent of men have a lifelong condition.\n", "question": "Does the story commit disease-mongering?", "explanation": "Even though\u00a0the prevalence of premature ejaculation is a subject open to disease-mongering, this report did not veer in that direction, noting how difficult to measure it is. \u00a0\u201cSome studies suggest that between 20 and 30 percent of men report early ejaculation concerns, but the International Society for Sexual Medicine estimates that about 4 percent of men have a lifelong condition.\u201d", "answer": 1}, {"article": "\"Nothing happens,\" he told Stahl.\nJohn Kanzius Research Foundation: Learn more about the research.\nApril 2008: The Kanzius Machine\n\nMD Cancer Center: Have questions about cancer?\nWhen he turned the device on, the temperature went up in that one area where the metal was and nowhere else.\nSo he wondered: if he injected a cancerous tumor with some kind of metal, would radio waves heat up the metal and cook the cancer cells to death, and only the cancer cells?\n", "question": "Does the story commit disease-mongering?", "explanation": "\n\n\nThe segment didn\u2019t dwell on cancer, but on the technology, so this criterion is not applicable in this case.\u00a0 ", "answer": 2}, {"article": "Natural Cycles uses a woman's body temperature and menstrual cycle data to tell her when she is fertile.\nFor starters, it can only protect against pregnancy, not STIs.\nBut natural family planning is not for everyone.\nYou don't actually need an app to practise natural family planning \u2013 although it does cut down on paperwork.\nBut for women like Natural Cycles co-founder Dr Elina Berglund, who want an alternative to hormonal contraception, it's an option worth pursuing.\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease mongering was evident in the article. It\u2019s quite clear that this is a device for use by women who do not want to get pregnant and while pregnancy is not a disease, an unwanted pregnancy is certainly a burden.", "answer": 1}, {"article": "A complex and expensive pacemaker-defibrillator can significantly improve the chance for survival among the tens of thousands of heart-failure patients with only mild symptoms, according to a major, multiyear clinical study.\n\nThe research, regarded as likely to change medical practice, showed that the device to \"resynchronize\" the hearts of such patients lowered the death rate by 29% in such patients over 40 months, compared to those who had a standard defibrillator implanted.", "question": "Does the story commit disease-mongering?", "explanation": "The story does not engage in disease-mongering.\u00a0It did make it sound like heart failure exacerbations happen rapidly, with minor changes in diet. This is not supported by the science. But this is a minor quibble.", "answer": 1}, {"article": "\u201cI keep waiting for the day when I have shortness of breath,\u201d he said.\nThat strategy alone, Dr. Biesecker said, has eliminated the vast majority of candidate genes.\nTo keep the focus on truly rare mutations, the researchers are excluding those that are present in both members of the Del Sontro family and 3 percent or more of the other study participants.\nOtherwise, lots of people would have early heart disease but no obvious risk factors.\nThe researchers are now searching for culprits among genes that remain \u2014 a search that could take years.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story describes this research through the prism of a single family with a strong history of early atherosclerosis, which is a risk factor for clinical events, but not a fait accompli. The story makes no attempt to quantify how common this situation is.\u00a0The story should have made it clearer that most cardiovascular disease occurs in individuals with traditional risk factors, and that addressing these factors is an effective way to reduce risk.", "answer": 0}, {"article": "Switching to AstraZeneca PLC's breast-cancer drug Arimidex after treatment with older drug tamoxifen not only helps women live longer, but also increases their chances of staying cancer-free after initial therapy for breast cancer, according to a study in the online edition of the Lancet Oncology medical journal.\n\nThe data, which come from more than 4,000 patients in three clinical trials, have shown that switching treatment from tamoxifen to Arimidex reduces the risk of dying by 29%.", "question": "Does the story commit disease-mongering?", "explanation": "The story does not engage is disease mongering. The story reports on a recent study relevant for women who have been diagnosed with early-stage breast cancer.", "answer": 1}, {"article": "\"Strikingly, these fasting-stimulated changes in the growth of vascular cells and subsequent immune alterations occur even after a single cycle of 24-hour fasting, and are completely reversed when mice start eating again,\" adds Yun Hye Kim.\nThe recurring regimen saw the animals being fed for two days, followed by one day without anything to eat.\nSuch fasting already shows benefits after only six weeks.\nTheir calorie intake was not adjusted otherwise.\nThe research team was led by Hoon-Ki Sung of The Hospital for Sick Children in Ontario, Canada.\n", "question": "Does the news release commit disease-mongering?", "explanation": "There was no disease mongering.", "answer": 1}, {"article": "Previous studies have found that aspirin users enjoyed a lower risk of colon cancer; a trial published earlier this year concluded that people who take a daily aspirin have as much as a 46% lower risk of colon, lung and prostate cancers, compared with non-users.\nYou can also continue the discussion on TIME\u2019s Facebook page and on Twitter at @TIME.\n\u201cGiven the high skin cancer incidence and the widespread and frequent use of NSAIDs, a preventive effect of these agents may have important public health implications,\u201d the authors, led by Sigrun Alba Johannesdottir from Aarhus University Hospital in Denmark, wrote.\n\u201cAlso, this potential cancer-protective effect should be taken into account when discussing benefits and harms of NSAID use.\u201d\n\nAlice Park is a writer at TIME.\nIt\u2019s not the first study to show a potential anticancer effect of aspirin and other similar painkillers \u2014 a class of medications known and nonsteroidal anti-inflammatory drugs, or NSAIDs.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story states that basal cell carcinoma (BCC) is \u201cthe most common form of skin cancer in the U.S.\u201d While the statement is true, BCC is also the slowest-growing and least dangerous form of skin cancer.\u00a0\u00a0 Nonetheless, we\u2019ll give the story the benefit of the doubt on this criterion.", "answer": 1}, {"article": "\u201cWith medicine, you always want to optimize a patient\u2019s outcome,\u201d Shastri said.\nPlus, the American Society for Reproductive Medicine (ASRM) committee opinion on IVM states that implantation rates for IVM\u2014between 5.5 and 21.6 percent\u2014 are a more reliable indicator of IVM success and are lower than expected for women of the same age who use IVF.\nAlthough IVF is still considered the gold standard, there\u2019s an infertility treatment available that is offering hope \u2014 in vitro maturation (IVM).\nThey also note that the technology hasn\u2019t been widely used and that there are no studies looking at the outcomes of birth defects or developmental delays.\nFor starters, since there is less time involved with IVM, women who are undergoing chemotherapy, radiation or plan to have surgery may be good candidates.\n", "question": "Does the story commit disease-mongering?", "explanation": "The article does a pretty good job of noting who is and is not a candidate for IVM. It could have done more to \u00a0give a broader picture of the rates of infertility among various groups of women in the U.S. It also could have noted that\u00a01-3% of all babies born in the U.S. are conceived with assisted reproductive technologies (IVF and its modifications).", "answer": 1}, {"article": "People with painfully damaged knees and hips have increasingly turned to \"minimally invasive\" joint-replacement surgery. But these relatively new procedures, though they promise shorter recuperation times, are raising concerns about potential complications.\n\nMany surgeons in recent years have performed joint replacements with ever smaller incisions. In minimally invasive surgery, the incision is typically about three to four inches long, roughly half that of traditional surgery. By cutting less of the surrounding tissue...", "question": "Does the story commit disease-mongering?", "explanation": "\nHip and knee osteoarthritis afflict millions of Americans, and this story fairly represents their predicament.", "answer": 1}, {"article": ".\n\u2022 Smoking cessation, weight loss (if indicated), limiting or avoiding alcohol, maintaining adequate levels of vitamin D and calcium, eating a healthy diet, and regular physical activity are suggested for all women with prior breast cancer\n\u2022 Non-pharmacologic therapies for VMS such as cognitive behavioral therapy, hypnosis, and acupuncture may be helpful as are vaginal lubricants and moisturizers\n\u2022 Several emerging approaches such as selective estrogen receptor modulators (SERMs), Tissue selective estrogen complex (TSECs), estetrol, and neurokinin B inhibitors show promise as useful agents to expand options for symptom relief with less breast cancer risk but have not yet been tested to confirm safety in women with prior breast cancer\n\nOther authors of the study include: Cynthia A. Stuenkel of the University of California, San Diego in La Jolla, Calif.; Susan R. Davis of the School of Public Health and Preventative Medicine, Monash University in Australia; JoAnn V. Pinkerton of the University of Virginia in Charlottesville, Va.; Ann Gompel of Paris Descartes University in France; and Mary Ann Lumsden of the University of Glasgow School of Medicine, Dentistry, and Nursing in Scotland.\nA comprehensive review published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism focuses on current and future approaches to management of menopausal symptoms after breast cancer.\n\"Following breast cancer, women should generally not be treated with menopausal hormone therapy but should instead focus on lifestyle modifications such as smoking cessation, weight loss, and regular physical activity,\" said the study's first author, Richard J. Santen, M.D., of the University of Virginia Health System in Charlottesville, Va. \"Pharmacologic agents are also available to treat women with severe symptoms.\nSanten and colleagues reviewed controlled clinical trials, observational studies, evidence-based guidelines, and expert opinion from professional societies to address the gap in treatment recommendations for management of menopausal symptoms after breast cancer.\n", "question": "Does the news release commit disease-mongering?", "explanation": "The review did not commit disease mongering. However, by omitting the breakdown of breast cancer survivors by age the release might give the impression that chemotherapy-induced menopause symptoms are higher than they actually are. As noted above, the study states that 43 percent of these women are older than 65 at diagnosis and would not have chemotherapy induced menopausal symptoms.", "answer": 1}, {"article": "\u2022 Retrograde menstrual flow: During a period, when a woman is shedding her uterine lining, some of that tissue can flow through her fallopian tubes and into her pelvis, which researchers think may cause endometriosis.\nSo it\u2019s no surprise it takes between three and 11 years after the onset of symptoms to diagnose endometriosis.\nWe have no idea about the long-term effects of taking the drug because there are no trials lasting for longer than a year, or how it stacks up against other painkillers (since the trials only compared it to placebo).\nThe success of surgery also depends on finding a skilled and experienced surgeon, and there\u2019s always the risk of surgical complications.\nSoon, it seems, women like Dunham with endometriosis pain will have a new option for relief.\n", "question": "Does the story commit disease-mongering?", "explanation": "The reader will find ample information about the unpleasant symptoms of endometriosis. In some areas, it comes close to disease-mongering, when pointing out very rare instances of women needing many surgeries, or a case study of one woman having endometrial tissue in her nose. However, endometriosis is a medical condition, and often under-diagnosed, so we\u2019ll rate this satisfactory.", "answer": 1}, {"article": "In a recent study, Canha and colleagues found that closed doors and windows led to higher levels of carbon dioxide, carbon monoxide and other substances such as formaldehyde.\nOn another night, the windows and door to the room were kept closed.\nThey each slept alone, and the bedroom layout with furniture arrangement was kept consistent.\nThey also wore a sensor that tracked their movements at night, including indications of restlessness.\nand we should play it safe in order to breathe better air during sleep.\u201d\n", "question": "Does the story commit disease-mongering?", "explanation": "There was no disease mongering.", "answer": 1}, {"article": "As part of the study, researchers analyzed data recorded in questionnaires submitted by 57,164 women in the California's Teacher's Study.\nCity of Hope is an independent research and treatment center for cancer, diabetes and other life-threatening diseases.\nThe team of researchers chose to focus on low-dose \"baby\" aspirin, because not only is it inexpensive and readily available as potential means of prevention, but because there are already a lot of people already taking it for prevention of other diseases such as heart disease and even colon cancer.\nIt was also able to look in detail at subtypes of breast cancer.\nIt is ranked as one of \"America's Best Hospitals\" in cancer by U.S. News & World Report.\n", "question": "Does the news release commit disease-mongering?", "explanation": "No disease mongering here. The release mentions that HER2 negative is the most common type of breast cancer.", "answer": 1}, {"article": "Although these trials showed a small reduction in the average number of night-time urinations with Noctiva compared to placebo, more patients treated with Noctiva were able to at least halve their number of night-time urinations, and patients treated with Noctiva had more nights with one or fewer night-time urinations.\nNoctiva is the first FDA-approved treatment for this condition.\nNoctiva should not be used in children.\nNoctiva is being approved with a boxed warning and a Medication Guide because it can cause low sodium levels in the blood (hyponatremia).\nNoctiva is taken daily, approximately 30 minutes before going to bed.\n", "question": "Does the news release commit disease-mongering?", "explanation": "The news release doesn\u2019t engage in disease mongering. It provides useful context about what the condition is, but not how common it is. That would have been a useful addition.", "answer": 1}, {"article": "In 2016, he was ranked the No.\ndegree.\nJust a few months ago, the FDA removed the black box warning from varenicline.\nFAU is ranked as a High Research Activity institution by the Carnegie Foundation for the Advancement of Teaching.\nFor more information, visit http://www.\n", "question": "Does the news release commit disease-mongering?", "explanation": "No disease mongering here, unless you count the unexplained nature of the \u201c17,000 premature deaths\u201d claim \u2014 which we already addressed under the section on benefits.", "answer": 1}, {"article": "Because a gene mutation impairs normal production of a blood clotting factor, patients may suffer excessive bleeding in the central nervous system or GI tract, or after surgery or an injury.\nThe current study sets the stage for clinical trials in humans.\nBased on kidney function, liver function, and blood measurements in the dogs, the treatment was safe, and did not elicit unwanted immune responses.\nThis success in large animals holds considerable potential for a safe, effective and long-lasting new treatment in humans with the same bleeding disorder.\nFactor VII deficiency is rare, found in about one in 300,000 to one in 500,000 people.\n", "question": "Does the news release commit disease-mongering?", "explanation": "There is no disease mongering.", "answer": 1}, {"article": "Fat tissue has been linked to higher levels of damaging metabolic stress compounds, so losing weight and becoming more fit may create more hospitable conditions for sperm and improve its quality and volume.\nThere are already plenty of reasons to exercise, and now better quality sperm is one more worth noting.\nThey wanted to see what effect different types of exercise, and different intensity activity, had on sperm quality and count.\nAnother group did high intensity exercise on the treadmill but in short interval bouts.\nIn the study, Behzad Maleki at Justus-Liebig University in Germany and his colleagues recruited 280 sedentary, middle-aged men and randomly assigned them to one of three exercise regimens, or to no exercise, and followed them for six months.\n", "question": "Does the story commit disease-mongering?", "explanation": "No evidence of disease mongering here.", "answer": 1}, {"article": "\u201cIt all depends on how you approach risk,\u201d Dr. Zelen said.\nBut, cancer experts said, no one would do such a study today when mammograms are generally agreed to prevent breast cancer deaths.\nShe worries about the small chance of benefit in light of the larger chance of finding and treating a cancer that did not need to be treated.\nMarvin Zelen, a statistician at the Harvard School of Public Health and the Dana-Farber Cancer Institute, who was a member of the research team said even though the mammography benefit is small, if he were a woman he would get screened.\nThe decision to be screened, she says, \u201cis a matter of personal preference.\n", "question": "Does the story commit disease-mongering?", "explanation": "\n\n\nThe story does not exaggerate the risk of breast cancer or the need to be screened for it.", "answer": 1}, {"article": "Why Biogen is breathing a sigh of relief with the latest Alzheimer\u2019s data\n\nWe already know Eli Lilly\u2019s big bet on Alzheimer\u2019s disease didn\u2019t work. But a deep dive into just how it failed has provided a bit of encouragement to Biogen and the many companies still hoping to succeed where their rival fell short.\n\nLilly\u2019s treatment, solanezumab, had no significant effect on the buildup of toxic brain plaques believed by many to be responsible for Alzheimer\u2019s neuron-destroying effects. The company had already disclosed that the treatment failed to improve patients\u2019 cognition and function, but the new data, released Thursday night, shed some important light on the underlying biology.", "question": "Does the story commit disease-mongering?", "explanation": "No mongering here.", "answer": 1}, {"article": "They find that there are real deleterious side effects but that they are manageable, and conclude the drug is worth using under the proper circumstances,\" he said.\nAnother expert, Dr. Norman H. Edelman, chief medical officer at the American Lung Association, and professor of preventive medicine, internal medicine, physiology & biophysics at Stony Brook University in New York, called the study \"very good bread-and-butter clinical research.\"\nThe efficacy of the drug has been proven previously, he noted, but this study provides an in-depth analysis of Avastin's safety profile under \"real life\" conditions, he added.\n\"Today we have a new option to treat non-squamous lung cancer, incorporating Avastin in chemotherapy regimens and in maintenance therapy,\" said lead researcher Dr. Lucio Crino, director of medical oncology at S. Maria della Misericordia Hospital in Perugia, Italy.\nThe funder was involved in study design, coordination of data collection, data analysis, data interpretation, and writing of the report, the journal noted.\n", "question": "Does the story commit disease-mongering?", "explanation": "\u00a0The story did not engage in disease mongering though it did include an estimate for the number of people who die from advanced non-squamous non-small cell lung cancer per year.\u00a0\u00a0The story should have been clear from the beginning that the study reported on the use of Avastin as a potential addition to treatment for\u00a0metastatic\u00a0non-squamous non-small cell lung cancer.", "answer": 1}, {"article": "Autologous CD34?\n\"The results of our study are even more provocative given that the outcomes represent the effect of a single treatment,\" wrote the researchers.\n\"These patients frequently have symptoms after having had standard therapies and are left with limited treatment options.\nThe patients, who were unresponsive to other treatments, were considered to have no other options (refractory).\nEncouraging early clinical trials suggest that cell therapy is an attractive treatment option for these patients, especially trials in which subjects were transplanted with autologous (self-donated) CD34+ cells.\"\n", "question": "Does the news release commit disease-mongering?", "explanation": "The release never defines or describes angina at all. The release treats angina like a disease, rather than as a symptom of underlying health problems. That\u2019s problematic. We do not want to downplay the condition in any way, but it is important to distinguish between symptoms (such as significant chest pain) and underlying causes (such as reduced blood flow to the heart).", "answer": 0}, {"article": "For more on childhood obesity, visit the U.S. Centers for Disease Control and Prevention.\nHealth benefits, including weight loss, seem to be a byproduct of the program, said Dr. David Katz, director of the Yale University Prevention Research Center.\n\"It [also] may be that when kids go to Head Start, it reduces stress in the household and frees up time and resources at home to dedicate to healthier eating patterns,\" she noted.\n\"This paper importantly suggests that some of the best strategies for controlling weight and promoting health may have little directly to do with either,\" said Katz, who wasn't involved in the study.\nAlmost one-quarter of preschool-aged children in the United States are overweight or obese, and obesity rates within Head Start populations are higher than national estimates, the study authors noted.\n", "question": "Does the story commit disease-mongering?", "explanation": "The reporter does not exaggerate the burden of obesity in children, especially those who are impoverished.", "answer": 1}, {"article": "Structural massage, commonly referred to as deep tissue massage, targets specific pain related tissues, ligaments and joints.\nAs for O'Brien-Murphy, she remains free of back pain, but not without some effort on her part.\nHe says massage relieved the pain for six months or more.\nFor an active person, this was devastating.\nNo one knows exactly how massage works to relieve pain, says Dr. Richard Deyo of Oregon Health Sciences University, who also took part in the study.\n", "question": "Does the story commit disease-mongering?", "explanation": "We wish the story had been more specific that those studied had low back pain of no identified cause lasting at least 3 months. But there wasn\u2019t any overt disease mongering.", "answer": 1}, {"article": "Cabozantinib, also known as XL184, is an oral drug designed to limit blood supply to tumors and to block two segments of a pathway used by cancer cells to grow and spread.\nThe drug reduced by 87 percent the risk of disease progression or death.\nBut two ovarian cancer patients died from cabozantinib-related side effects - one from bowel fistula and one from intestinal perforation.\nThe study results were reported on Monday at the American Society of Clinical Oncology\u2019s annual meeting.\nExcluding patients on placebo, the median survival without disease progression was 29 weeks.\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease mongering of late-stage prostate cancer.", "answer": 1}, {"article": "Error code 404. Something went\n\nwrong and we can't seem to find\n\nthe page you're looking for.\n\n Report a broken link.", "question": "Does the story commit disease-mongering?", "explanation": "Not all people with lymphedema have symptoms as severe as the patient featured in this story, whose arm was \u201cpainfully swollen to lift anything heavy or even fit into her usual clothing.\u201d That should have been conveyed more clearly.\nThe story also quotes a surgeon saying that typical patients have \u201chad that swelling for a while\u201d and \u201ctreatment is an uphill battle.\u201d Of course, surgeons tend to see only a segment of cases that haven\u2019t responded well to other treatments.\nBreastcancer.org calls surgery \u201can option of last resort for severe lymphedema that does not respond to treatment. Most people with lymphedema would not be considered candidates for surgery.\u201d", "answer": 0}, {"article": "\"Once injected into a patient's artery, many stem cells are lost due to the combination of tissue blood flow, which can wash out stem cells, and cardiac contraction, which can squeeze out stem cells.\n\"This remarkably simple method could easily be coupled with current stem cell treatments to enhance their effectiveness.\"\nThe U.S. National Library of Medicine has more on heart disease.\nMarban and his wife, Linda, are founders of a company that has filed patents for the techniques.\nThe study was published online April 8 in the journal Circulation Research.\n", "question": "Does the story commit disease-mongering?", "explanation": "Not applicable \u2013 no meaningful discussion of heart damage in humans. ", "answer": 2}, {"article": "Proton therapy is an advanced type of radiation treatment that uses a beam of protons to deliver radiation directly to the tumor, destroying cancer cells while sparing healthy tissues.\nThe research, published in JAMA Oncology, reported an overall survival (OS) of 26.5 months.\nIn contrast, the historical OS rate with standard of care concurrent chemotherapy and traditional radiation was 16 months at the time when the study was designed.\nWhile the study's survival, recurrence rates and toxic effects are still favorable when compared to rates associated with the most advanced traditional photon radiation therapy, intensity modulated radiation therapy (IMRT), technology to diagnose and stage the disease, as well all treatment modalities have significantly improved.\nOf note, said Chang, no patients developed the most severe, or grade five, toxicities, as seen in patients who receive standard of care.\n", "question": "Does the news release commit disease-mongering?", "explanation": "There is no disease mongering in the release. Despite the favorable reporting of outcomes, most patients were dead at 5 years.", "answer": 1}, {"article": "\"Patients with acute coronary syndrome have options to prevent recurrent events,\" study lead author Dr. Kenneth W. Mahaffey, co-director of cardiovascular research at the Duke Clinical Research Institute, and associate professor of medicine at Duke University Medical Center, said in an AHA news release.\nA study author agreed that for most patients, using the drug with a lower dose of aspirin is usually warranted.\nBrilinta has already been approved for use in many other countries.\nThe findings were reported Monday in an American Heart Association online conference.\n\"A higher aspirin dose (325 mg versus 81 mg) increases the risk of bleeding without increasing the efficacy of the drug.\"\n", "question": "Does the story commit disease-mongering?", "explanation": "The population is pretty well specified in the article as those with acute coronary syndromes, and it explains that the FDA is considering an indication for these patients who are undergoing angioplasty or stenting.", "answer": 1}, {"article": "Lead researcher Professor David Newby, of the BHF Centre for Cardiovascular Science at the University of Edinburgh, said: \"This relatively simple heart scan ensures that patients get the right treatment.\nThis is the first study to look at the impact of the scans on long-term survival rates.\nResearchers say current guidelines should be updated to incorporate the scans into routine care.\nThis is the first time that CT guided management has been shown to improve patient outcomes with a major reduction in the future risk of heart attacks.\nHeart scans for patients with chest pains could save thousands of lives in the UK, research suggests.\n", "question": "Does the news release commit disease-mongering?", "explanation": "There is no disease mongering. Some information on the prevalence of heart attacks among the patient population would put the problem in context.", "answer": 2}, {"article": "The results suggested that children who went through a year of sublingual therapy followed by one to two years of oral immunotherapy were less likely to have significant allergic reactions when undergoing the oral immunotherapy.\nStill, it did not eliminate all symptoms.\nThese kids were severely allergic to cow's milk.\nAnd so far there's no cure.\nBut only one-third have longterm protection.\n", "question": "Does the story commit disease-mongering?", "explanation": "NO disease mongering at play here.", "answer": 0}, {"article": "In 37 years as a police officer, Edwin Michel coped with a plane crash, a sniper, wildfires and three bullet wounds.\n\nNothing much rattled him until he was diagnosed with prostate cancer in November 2016. His doctor said the cancer wouldn\u2019t kill him but Mr. Michel, now 76 years old, wasn\u2019t entirely reassured. He felt more confident after a genomics test later revealed his prostate cancer was very low risk. The test, known as Oncotype DX, takes a sample from a prostate biopsy and analyzes 17 genes in it to estimate how aggressive...", "question": "Does the story commit disease-mongering?", "explanation": "Men diagnosed with prostate cancer often have to make difficult treatment decisions that reconcile their fears of cancer progression against their fears of treatment complications.\u00a0 This story did a good job of pointing out the challenges here.", "answer": 1}, {"article": "March 20, 2011 -- Elevated levels of a group of five amino acids may predict the development of diabetes years before any noticeable symptoms occur, according to a new study.\n\"They also raise the possibility that, in selected individuals, these measurements could identify those at highest risk of developing diabetes so that early preventive measures could be instituted.\"\nResearchers say metabolic abnormalities that eventually lead to type 2 diabetes can be present years before diabetes is diagnosed.\n\"These findings could provide insight into metabolic pathways that are altered very early in the process leading to diabetes,\" says researcher Thomas Wang, MD, of Massachusetts General Hospital's Cardiovascular Research Center, in a news release.\nFor example, insulin resistance, where the body does not use insulin effectively, occurs long before blood sugars reach the level seen in type 2 diabetes.\n", "question": "Does the story commit disease-mongering?", "explanation": "", "answer": 1}, {"article": "The U.S. Food and Drug Administration said Tuesday it has approved Cotellic, a drug produced by Swiss biotech company Roche, for use in combination with the vemurafenib medication as a treatment for advanced melanoma.\n\nThe drugs are intended to target the illness after it has spread to other parts of the body or can\u2019t be removed by surgery.", "question": "Does the story commit disease-mongering?", "explanation": "There is no disease mongering here.\u00a0 Advanced melanoma is a terrible disease and many treatments fail.", "answer": 1}, {"article": "Inflammation can make urination difficult.\nBissada is now conducting follow-up research to support the first study's findings.\nCase Western Reserve dental researchers Nishant Joshi, Catherine Demko and Robert Skillicorn; and University Hospitals Case Medical Center researchers Donald Bodner, Lee Ponsky, Sanjay Gupta and Gregory T. MacLennan contributed to the study.\nSymptom scores on the IPSS test also showed improvement.\nThose with the highest levels of inflammation benefited the most from the periodontal treatment.\n", "question": "Does the news release commit disease-mongering?", "explanation": "The release actually offers no incidence or prevalence data at all, and as a consequence, makes no overstatements about either gum disease or inflammatory disorders that are linked to it.", "answer": 1}, {"article": "Drugs such as ipilumumab can seem like breakthroughs to doctors because they help 15% of patients.\nAnd none are risk-free.\nA few years ago, that would have been a very short list.\nAll improve survival by a few months.\nNone of the new drugs works for everyone.\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease-mongering in the story.", "answer": 1}, {"article": "June 28, 2010 -- Cholesterol-lowering statin drugs appear to reduce the risk for prostate cancer recurrence in patients who have had a surgical procedure called radical prostatectomy.\nBut the fact that the fewest recurrences were seen in men who took the highest statin doses is compelling, says senior investigator Stephen J. Freedland, MD, of the Duke Prostate Center.\n\u201cStatin users may see their doctors more often and may be more health conscious in general, and it has been suggested that this could explain the observed reduction in risk,\u201d Freedland tells WebMD.\nThose who took the highest doses saw their recurrence risk drop by half.\nThe research does not prove that taking cholesterol-lowering drugs directly slows the growth and progression of prostate cancer.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story presents the scope of the disease clearly and concisely. \"About one man in six will be diagnosed with prostate cancer during his lifetime, and one in 35 will die of the disease, according to the American Cancer Society. In the U.S. alone, roughly 190,000 new cases of prostate cancer were diagnosed last year.\" But why aren\u2019t we given any estimates of recurrence, since that\u2019s what the story is about?\u00a0", "answer": 1}, {"article": "The company, which says gammaCore is already available in the European Union, expects to start selling it later this year in the U.S.\n\nVagus nerve stimulation is used to treat a range if disorders, including epilepsy, depression and overeating.\nRelated: New Migraine Drugs Would Treat Pain Before it Starts\n\nSilberstein helped test the device, which users press against the neck.\nThe device is a vagus nerve stimulator and it\u2019s not entirely clear how it works.\nThis went up to about a third of patients with so-called episodic cluster headaches.\nThe Food and Drug Administration approved a device on Tuesday meant to treat cluster headaches \u2014 a rare form of headache that affects mostly men.\n", "question": "Does the story commit disease-mongering?", "explanation": "There was no disease mongering about cluster headaches. The article provides context about the problem and how rare it is.", "answer": 1}, {"article": "All rights reserved.\n\"You can shop for a toaster\" better than for prostate treatment, he said.\nYet it has a track record from its breast cancer test.\n\"It went both ways \u2014 that was the remarkable thing.\nHe said a gene test may have made him more comfortable with that decision.\n", "question": "Does the story commit disease-mongering?", "explanation": "There was no disease mongering of prostate cancer in the story.", "answer": 1}, {"article": "\"Of more than 400 patients in the trial, we found those who received Tamsulosin passed their large kidney stones more often than the placebo group.\nEMF Australasia awarded more than $270,000 to support Dr Furyk's research, through its Queensland Research Program, which is funded by the Queensland Government Department of Health.\nThe Foundation was established in 2007 with the support of the Queensland Government.\nEMF Australasia Chair, Associate Professor Sally McCarthy said this research had the potential to help millions of Australians suffering with this extremely painful condition.\n\"Kidney stones are a bit of a mystery, occur frequently in the community and generally affect young, healthy adults,\" Dr Furyk said.\n", "question": "Does the news release commit disease-mongering?", "explanation": "No disease-mongering here.", "answer": 1}, {"article": "Paul is on Procter & Gamble's advisory board but holds no stock in the company and will not profit financially.\nIn the study, funded by an unrestricted research grant from Procter & Gamble, makers of Vicks, researchers took 138 children between the ages of 2 and 11, with symptoms like cough, congestion, runny nose and restless sleep that lasted seven days or more.\nChildren in all three groups got better, but those treated with the VapoRub saw the greatest improvement, and parents in this group also had improved sleep, the study found.\nThe current study shows that Vaporub is more effective than placebo.\"\nThat night, 30 minutes before bedtime, Vicks or petroleum jelly was rubbed onto the child's chest and neck.\n", "question": "Does the story commit disease-mongering?", "explanation": "\n\n\nThe story accurately describes the children in the study as having \u201csymptoms like cough, congestion, runny nose and restless sleep that lasted seven days or more.\u201d", "answer": 1}, {"article": "Followers of the popular regime eat during an eight-hour window, in this case between 10 a.m. and 6 p.m. And for the 16 hours in between, they consume only calorie-free drinks, such as water.\nThe researchers compared the results to existing data from a separate weight loss trial carried out between 2011 and 2015.\n\"There are also many studies that either report no overall effect or sometimes the opposite.\nHowever, their fat mass, insulin resistance and cholesterol levels were similar to the control group's.\nFor 12 weeks, the scientists measured various factors, including the participants' fat mass, blood pressure and cholesterol and glucose levels.\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease-mongering here.", "answer": 1}, {"article": "But Johannesdottir added that \"we hope that our finding will inspire more research on skin cancer prevention.\n\"Meanwhile, the most important prevention against skin cancer remains sun protection.\"\nWhat's more, the apparent protective impact of both prescription and nonprescription NSAIDs on skin cancer risk seems to be stronger the longer someone takes them.\n\"Now we have a better understanding that inflammation also plays a significant role in cancer formation and even skin cancers,\" he said.\nThe study appears in the May 29 online issue of the journal Cancer.\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease-mongering.", "answer": 1}, {"article": "The problem is that over the years the stomach stretches, and when that happens, Watson says, \"Patients are able to eat more at one sitting and they feel hungrier more often.\"\nThat's when she opted for bariatric surgery.\nAnd research conducted over the past decade suggests it works.\nFor Friedman, it did the trick.\nThe surgery worked.\n", "question": "Does the story commit disease-mongering?", "explanation": "Given the high incidence of obesity in the United States, exaggerating the seriousness of the problem is unnecessary. No disease mongering here.", "answer": 1}, {"article": "A new method for performing a \u201cvirtual\u201d colonoscopy that requires less unpleasant preparation was shown in a new study to accurately detect larger precancerous polyps\u2014and was a better experience for patients.\n\nThe second-leading cause of cancer deaths in the U.S., colon cancer can be prevented if precancerous polyps\u2014known as adenomas\u2014are found and removed during a colonoscopy\u2026.", "question": "Does the story commit disease-mongering?", "explanation": "There was no disease mongering in the story.", "answer": 1}, {"article": "Founded 119 years ago as a nonprofit hospital, National Jewish Health today is the only facility in the world dedicated exclusively to groundbreaking medical research and treatment of patients with respiratory, cardiac, immune and related disorders.\nPowerful antibiotics are commonly prescribed for eczema, but they kill good bacteria on patients' skin along with the bad.\nCreams containing corticosteroids are also often prescribed to eczema patients, but they come with harsh side effects, and patients usually can't tolerate them for long periods of time.\nIt may seem strange to fight bacteria with more bacteria, but it could lead to a long-term solution for eczema patients\n\nEczema is the most common skin disease worldwide.\nPeople suffering from it often deal with a lifetime of painful symptoms.\n", "question": "Does the news release commit disease-mongering?", "explanation": "No disease mongering. Atopic dermatitis is very common and difficult to treat.", "answer": 1}, {"article": "Parkinson's disease is a degenerative condition that affects the central nervous system.\n\"Berries could be a neuroprotective agent.\n\"For total flavonoids, the beneficial result was only in men.\nPeople can include berries in their regular diet.\nBut, he added, it's important for people to realize that this research isn't applicable to people who already have the disease.\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease-mongering.", "answer": 1}, {"article": "A growing number of doctors who treat the estimated 6.4 million American children diagnosed with A.D.H.D.\nOne possible reason, as the report noted, was that many children refuse to continue taking medication after a year or so, something most parentsof such children well know.\nAnd other research has raised new concerns.\nmedication is that a \u201cgold-standard\u201d study would require researchers to assign children randomly to groups that either received medication or didn\u2019t.\nSuch a practice has been deemed unethical due to the widespread belief that the medication can help struggling children, at least in the short-term.\n", "question": "Does the story commit disease-mongering?", "explanation": "It is clear that the discussion is about the more than 6-million children in the United States who already have been diagnosed with ADHD.", "answer": 1}, {"article": "ASTRO publishes three medical journals, International Journal of Radiation Oncology\n\u2022 Biology\n\u2022 Physics (www.redjournal.org), Practical Radiation Oncology (www.practicalradonc.org) and Advances in Radiation Oncology (www.advancesradonc.org); developed and maintains an extensive patient website, RT Answers (www.rtanswers.org); and created the Radiation Oncology Institute (www.roinstitute.org), a nonprofit foundation to support research and education efforts around the world that enhance and confirm the critical role of radiation therapy in improving cancer treatment.\n\u201cAfter following patients for more than five years, we found that serious side effects from a brief course of SBRT were uncommon and that cancer control rates were very favorable compared to historical data.\nSpecifically in the low-risk group, the five-year RFS rate was 97.3 percent, which is superior to the 93 percent historical comparison DFS control rate (p = 0.014).\n\u201cSingle-institution studies on the use of SBRT as the primary treatment for prostate cancer have illuminated the treatment as a cost-effective and faster alternative to IMRT,\u201d said Robert Meier, MD, lead author of the study and a radiation oncologist at Swedish Medical Center in Seattle.\nBiochemical failure was assessed using the ASTRO-consensus and the nadir+2 definitions.\n", "question": "Does the news release commit disease-mongering?", "explanation": "The news release does not commit mongering. However, as noted above, the patients enrolled in the trial were a very low risk population and one could argue that some of these patients may not have needed treatment at all.", "answer": 1}, {"article": "\u201cI don\u2019t know why it is not being incorporated in the US,\u201d she said.\nAnd the blood test is reliable as early as seven weeks into the pregnancy, whereas ultrasound is not.\nThe test may be particularly valuable for families that harbor sex-linked genetic disorders like hemophilia, they add.\nHowever, the current non-invasive alternative \u2014 an ultrasound done at the end of the first trimester \u2014 isn\u2019t always good at spotting a baby\u2019s sex, Bianchi\u2019s team reported in the Journal of the American Medical Association.\nSome European hospitals already rely on the method, called cell-free fetal DNA, although it\u2019s not available from doctors in the U.S.\n\n\u201cWhat they are finding in England is that many women are not going on to have the invasive tests,\u201d Bianchi told Reuters Health.\n", "question": "Does the story commit disease-mongering?", "explanation": "Reuters clearly discusses the alternatives for determining fetal sex, including chorionic villi and amniotic fluid sampling, and ultrasound. They don\u2019t exaggerate the benefits or problems with gender testing.", "answer": 1}, {"article": "offers a range of quality ingredients that are innovative and scientifically validated to address complex challenges for customers in the dietary supplement, food and beverage space using technology-driven, sustainable solutions with application support within a global regulatory framework.\n\"Capsimax is supported by multiple studies with findings showing safety, increased lipolysis and satiety and improved healthy body composition.\nFor more information on the MR Study or Capsimax, please contact Sara Zoet at s.zoet@omniactives.com.\nMorristown, N.J., Aug. 7, 2017 - As we age, managing healthy weight may become more difficult due to a slowing metabolism, however, help may come from a fiery source -- the capsicum pepper.\nThe company develops IP-protected, science-backed branded ingredients from natural sources using cutting edge technologies.\n", "question": "Does the news release commit disease-mongering?", "explanation": "There is no disease mongering.", "answer": 1}, {"article": "She is 5-foot-7, and her starting weight was 165 to 170; after two months she had lost about 28 pounds.\nBut Dr. Ravussin and Dr. Hadley cautioned that the study was preliminary, and that it did not prove that calorie restriction could make people healthier or add years to their lives.\nPart of the reason for the study, Dr. Ravussin said, was to find out whether people could stand calorie restriction.\nHe called the results \"striking,\" even though the experiment was only a pilot study for a two-year trial of calorie restriction due to begin in the fall.\nA six-month study in 48 people directed by Dr. Ravussin, being published today in The Journal of the American Medical Association, is the first rigorous test of calorie restriction in people who are overweight but not obese.\n", "question": "Does the story commit disease-mongering?", "explanation": "There isn\u2019t any discussion of how many Americans are overweight but not obese, so we can\u2019t judge the story unsatisfactory on this criterion. However, we are tempted to do so when the story states, without attribution or evidence to back it up: \u201cThe notion that going hungry could be the fountain of youth has captivated scientists and the public.\u201d ", "answer": 1}, {"article": "When it reaches the area of the heart that causes abnormal rhythms, the tissue is ablated, or destroyed.\nThe procedure has been used to treat arrhythmias for years.\nMedtronic shares were up 3.7 percent to $45.55 in late-morning trading on the New York Stock Exchange.\nA small pilot study funded by St. Jude Medical Inc STJ.N compared the two therapies in a sicker population of patients and also found that the procedure worked better than drugs.\nIt significantly raises the risk of stroke.\n", "question": "Does the story commit disease-mongering?", "explanation": "There was no overt disease-mongering of atrial fibrillation. ", "answer": 1}, {"article": "Moderate-fat diet with one avocado a day lowered 'bad' cholesterol by 13.5 mg/dL\n\nThe researchers found that participants' levels of low-density lipoprotein (LDL) - referred to as the \"bad\" cholesterol - were an average of 8.3 milligrams per deciliter (mg/dL) lower after following the lower-fat diet without an avocado and 7.4 mg/dL lower after following the moderate-fat diet without an avocado, compared with their baseline average.\n\"That is not the real-world,\" says Kris-Etherton, \"so it is a proof-of-concept investigation.\"\nIt should be noted that this research was supported by the Hass Avocado Board, but the researchers say the organization played no other role in the study.\nAvocados, however, can also be eaten with salads, vegetables, sandwiches, lean protein foods (like chicken or fish) or even whole.\"\nOur Knowledge Center article on the health benefits of avocado reveals some of the other ways the food may be good for us, as well as the potential risks of avocado consumption.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story does not resort to disease mongering to make its case.", "answer": 1}, {"article": "Hair changes about as fast as grass grows, which is to say it\u2019s extraordinarily slow and not visible to anyone checking impatiently in the mirror every day.\nOne is how much emphasis the company places on compliance, the major stumbling block in the efficacy of any treatment, said Dr. Senna, an author of studies on the subject.\nClients must also use the company\u2019s shampoo, conditioner and styling products, forsaking all others \u2014 a psychological as well as a financial buy-in, Dr. Senna said.\nFor now, Maryanne Senna, a dermatologist and the director of the Hair Academic Innovative Research Unit at Massachusetts General Hospital in Boston, said the best she can tell patients who ask \u2014 and a lot of them do \u2014 is that Harklinikken won\u2019t do any harm.\n\u201cDon\u2019t get me wrong \u2014 I really want it to work,\u201d said Dr. Senna, who also teaches at Harvard Medical School.\n", "question": "Does the story commit disease-mongering?", "explanation": "There\u2019s no disease mongering. However, we take issue with the use of the word \u201ccure\u201d in the headline because it\u2019s ill-defined; even the company says users achieve no more than 60 percent restoration of their lost hair. And it\u2019s debatable whether hair loss is a disease that needs to be cured. The story also plays into the firm\u2019s marketing mystique by calling the treatment \u201ca customized hair extract that\u2019s given only to those who pass a fairly rigorous selection process\u201d and saying it \u201cinspires great loyalty.\u201d", "answer": 1}, {"article": "During the last three months of 2008 \u2014 the most recent data available that allowed a comparison among robotic, open and laparoscopic surgeries \u2014 more than half of all prostate removals involved robot-assisted surgery.\nEmphasis should be lmited on procedure, he said, as opposed to surgical skill.\n\u201cYears ago, this was thought to be the be-all-end-all operation, particularly with prostate surgery.\n\"And the reality of it is that... there are some benefits -- but not as much as we had hoped.\"\nSOURCE: bit.ly/zZIYa1\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease mongering at play here.", "answer": 1}, {"article": "Both acupuncture and Alexander Technique prove effective for long-term relief of chronic neck pain\n\nIn a randomized, controlled trial, both acupuncture and the Alexander Technique led to long-term significant reductions in neck pain and associated disability compared with usual care alone.\nThe study is published in Annals of Internal Medicine.\nTo speak with the lead author, Dr. Hugh MacPherson, please contact David Garner at david.garner@york.ac.uk or +44 (0) 1904 322153.\nNote: For an embargoed PDF, please contact Cara Graeff.\nUsual care for neck pain generally consists of prescribed medications and visits to physical therapists and other health care professionals.\n", "question": "Does the news release commit disease-mongering?", "explanation": "There is no disease-mongering here about\u00a0chronic neck pain.", "answer": 1}, {"article": "This signal is passed to a computer that decodes it, and the resulting instruction is then sent to a sleeve he wears on his forearm that stimulates the muscles that move his wrist and fingers.\nThere are still many challenges to be overcome to bring this work out of the lab and into the lives of the millions of people who are paralysed.\nThat's why the device requires training every time Burkhart uses it.\nOur understanding of how brain signals change will also be crucial to making this technology usable on a large scale.\nFor starters, the device that records the brain signals will need to be much smaller so it's fully implanted under the paralysed person's skin.\n", "question": "Does the story commit disease-mongering?", "explanation": "Paralysis from spinal cord injuries is a devastating condition, so the story is not overstating the situation facing patients.", "answer": 1}, {"article": "\u2022 Try to stay indoors, and avoid mowing lawns or raking leaves.\nThey can raise blood pressure and cause jitters, and some people are more susceptible than others.\nOver-the-counter treatments should not take the place of professional care \u2014 especially if you have never been formally diagnosed with allergies, if you have additional medical problems or if your symptoms persist or worsen, Eghrari-Sabet and Sublett say.\nThe non-prescription steroid nasal sprays are selling for about $17 to $23 for a one-month supply (at the typical two-squirts per nostril adult starting dose).\nThose include allergy shots and, for a few patients who qualify, newer immunotherapy pills that desensitize people to grass and ragweed pollens.\n", "question": "Does the story commit disease-mongering?", "explanation": "While there was no overt disease mongering, the story suggests that anyone who has allergies needs to see an allergist, which is not accurate and might be said to constitute a sort of \u201cspecialty service mongering.\u201d In the majority of cases, the appropriate care setting is primary care. Inappropriate specialty care is a major contributor to rising health care costs.", "answer": 1}, {"article": "There had been no research on whether that was beneficial.\nFor any individual woman, the odds of developing \u201ccontralateral\u201d breast cancer \u2014 that is, in the opposite breast \u2014 are still lower than 200-to-1 per year.\nAbout two-thirds of breast cancers are hormone-receptor positive, and they have a good prognosis.\nPut another way, the risk of cancer returning in the original or the opposite breast was 34 percent lower in women on 10 years of letrozole compared with those who stopped after five.\nThirteen of the women taking the drug for an additional five years developed breast cancer in the opposite breast during the study, compared with 31 taking the placebo; 55 and 68, respectively, developed a recurrence of cancer in the original breast.\n", "question": "Does the story commit disease-mongering?", "explanation": "There is no disease mongering in terms of the overall risk of developing breast cancer or the risk of recurrence.", "answer": 1}, {"article": "Co-authors are: Leslie Donato, Ph.D.; Sandra Bryant; Grant Spears; Peter Berger, M.D.\n\u201cThere is a need to identify patients at increased risk for cardiovascular events so that we can test strategies to prevent those events.\nBut when researchers examined cardiovascular disease in this population by ceramide scores, people with the highest levels of ceramides were four times more likely to have an event compared with those with the lowest (7.8 vs. 2.2 percent, respectively).\nThe study found that individuals with the highest levels of blood ceramides were found to have a 3- to 4-times greater risk of having a cardiovascular event compared with those with the lowest ceramide score, regardless of their LDL cholesterol level or the presence of a blockage in the heart\u2019s arteries.\n\u201cOur research suggests that evaluating ceramide levels in patients who are not at immediate risk for coronary artery disease events may help cardiologists decide who could benefit from proactive and preventive treatment, such as statins, or lifestyle changes to prevent a serious cardiac event down the road,\u201d says Jeff Meeusen, Ph.D., a clinical chemist, co-director of Cardiovascular Laboratory Medicine at Mayo Clinic and the study\u2019s lead author.\n", "question": "Does the news release commit disease-mongering?", "explanation": "Heart disease is a serious and common problem. However, the news release skirts the line here by stating in the second paragraph that \u201cindividuals with the highest levels of blood ceramides were found to have a 3- to 4-times greater risk of having a cardiovascular event compared with those with the lowest ceramide score, regardless of their LDL cholesterol level or the presence of a blockage in the heart\u2019s arteries.\u201d Five paragraphs later, it provides the absolute risk information mentioned earlier. What\u2019s missing here are data explaining how heart disease risks for individuals with low LDL cholesterol, no blockages and high ceramide levels compare to the risks among individuals with high LDL cholesterol levels and/or evidence of heart artery blockage. Those numbers would\u2019ve helped put the \u201c3- to 4-times greater risk\u201d in context.", "answer": 1}, {"article": "A healthy intake of vitamin D in the first year of life appears to set children up to have more muscle mass and less body fat as toddlers, according to a new study published in the journal Pediatric Obesity.\nThe additional benefit in terms of body composition came as a surprise for the research team.\nThis amount is in line with current Canadian health guidelines.\nBut the body scans used to assess bone density also allowed the team to measure the children's muscle and fat mass.\nThe new study confirmed the importance for the development of strong bones of a vitamin D supplement of 400 IU/day during a baby's first year.\n", "question": "Does the news release commit disease-mongering?", "explanation": "The news release doesn\u2019t hype pediatric obesity.", "answer": 1}, {"article": "By Amy Norton NEW YORK (Reuters Health) - People with multiple sclerosis have long said that smoking marijuana helps ease their painful muscle cramping.\nBefore and after each treatment, an independent rater assessed the patients\u2019 muscle spasticity.\nAnd a new clinical trial suggests they are not just blowing smoke.\n\u201cWhat effects that might have had on the results is unclear.\u201d\n\nCorey-Bloom said that should not have influenced the spasticity findings, since an independent researcher (who didn\u2019t know whether patients were smoking marijuana or the placebo) rated spasticity using a standard scale.\nBoth LaRocca and Corey-Bloom said there were limitations to the current study.\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease-mongering of spasticity of MS.", "answer": 1}, {"article": "Prescribing testosterone for age-related deficiency \u2014 which is only vaguely defined \u2014 took off in 2000. The trend was driven not by solid scientific evidence, but by the introduction of convenient, rub-on testosterone products, the first being Androgel. Many men are put on testosterone with no tests of their levels or despite tests showing normal levels, a study of Medicare claims found.", "question": "Does the story commit disease-mongering?", "explanation": "If anything this article is the opposite of disease mongering. It reports results of a study that was commissioned out of concern that testosterone is overprescribed to older men and that\u00a0many men\u00a0who use it either have normal testosterone levels have never been tested.\nOne minor\u00a0concern is that the context/fact-checking is delivered subtly and may be missed on a quick read.\nFor example:\nAbbVie, which donated its leading brand, Androgel, to the trials, said in a statement that the company is \u201ccommitted to our patients and is proud of our continuous support of research that advances science for the benefit of hypogonadism patients.\u201d\nAs explained elsewhere, hypogonadism occurs when the body doesn\u2019t produce enough of the hormone due to disease, injury, or chemotherapy.\u00a0\u00a0It\u2019s the condition for which testosterone-replacement therapy is approved\u2013not experimental use for mood, libido, low bone density, etc.", "answer": 1}, {"article": "For this study, researchers counted circulating tumor cells in 302 breast cancer patients who were about to undergo surgery but who hadn't yet received chemotherapy.\nThe problem is that just having circulating tumor cells may not be enough information to foretell the future, she noted.\nThe more tumor cells a woman had in her bloodstream, the higher the likelihood of relapsing or dying, according to the report.\nIn the new study, if even one cell was detected in the bloodstream, a woman had a greater chance of her cancer recurring and of dying.\nAlthough the test may not be far off in terms of clinical practice, \"we need additional studies,\" Lucci said.\n", "question": "Does the story commit disease-mongering?", "explanation": "There is no disease mongering.", "answer": 1}, {"article": "\u201cThis is literally on the cutting edge of where the field is,\u201d Dr. DeKosky said.\n\u201cThis is what everyone is looking for, the bull\u2019s-eye of perfect predictive accuracy,\u201d Dr. Steven DeKosky, dean of the University of Virginia medical school, who is not connected to the new research, said about the spinal tap study.\nAnd when \u2014 researchers optimistically are saying \u201cwhen\u201d these days \u2014 drugs are shown to slow or prevent the disease, the thought is that people will start having brain scans or spinal taps for Alzheimer\u2019s as routinely as they might have colonoscopies or mammograms today.\nIn the research studies, patients are often not told they may have the disease, but in practice in the real world, many may be told.\nThey note that it is not reliable enough \u2014 results can vary by lab \u2014 and has been studied only in research settings where patients are carefully selected to have no other conditions, like strokes or depression, that could affect their memories.\n", "question": "Does the story commit disease-mongering?", "explanation": "1clip_filelist.xml\"/>\n\n\n\nThis story does not exaggerate the prevalence or seriousness of Alzheimer\u2019s Disease. However, by incorrectly stating that the test can identify people who are \"on their way to developing Alzheimer\u2019s disease,\" the story encourages confusion between risk factors for a disease and the disease itself. ", "answer": 1}, {"article": "\"Here in the U.S., we do things differently,\" he said.\nMONDAY, Aug. 15, 2011 (HealthDay News) -- A traditional Chinese herbal treatment may reduce fever from H1N1 (\"swine flu\") influenza just as well as the prescription medication Tamiflu, a new study suggests.\nEven though the ephedra-containing herbal is not readily available in the United States, the M-Y herbal formula is available in many countries besides China, including Korea, Japan, India and Germany, the study authors noted.\nAll three approaches helped to resolve fever sooner than no intervention whatsoever, the authors said, noting it appeared that fever dissipated fastest when M-Y and Tamiflu were given together.\nHowever, none of the treatment methods appeared to be superior in terms of overall viral control, and side effects were minimal in all cases.\n", "question": "Does the story commit disease-mongering?", "explanation": "Although the writer didn\u2019t hype the problem of influenza (which does result in a large number of deaths every year), the majority of those with the flu do not require treatment. So the story edges into disease-mongering territory when it suggests that Tamiflu was the \u201ctreatment of choice\u201d for most cases of H1N1. In fact, antiviral drugs were unconditionally recommended by WHO guidelines only for certain groups, such as those with severe illness or who were at\u00a0risk of developing a severe illness.\u00a0Patients like those in this study who had \u201cvery mild\u201d cases of the flu were not necessarily candidates for treatment with antivirals because their illnesses were typically short and self-limited and would not\u00a0be substantially affected by taking Tamiflu. In addition, overuse of antivirals encourages the development of drug resistant virus strains. By failing to draw this distinction, the story leads readers to believe that every case of H1N1, even very mild ones,\u00a0should be treated with Tamiflu, which is not accurate.", "answer": 0}, {"article": "NEW YORK -- A new study says yoga may be as good a treatment for back pain as physical therapy.\nOne person who might agree is 74-year-old Judith Zaborowski, who took up yoga more than 10 years ago to help with her aching back.\nDr. Robert Saper at Boston Medical Center is one of the authors.\n\"I feel, the more that one can do for one's self and not depend on medication, the healthier it is for your body,\" Zaborowski said.\n\"Yoga was as effective as physical therapy for reducing pain intensity,\" Saper said.\n", "question": "Does the story commit disease-mongering?", "explanation": "There was no disease mongering. But we thought the story tried too hard to raise the specter of opioid addiction, which was not the focus of the research itself. If you\u2019re going to go there, then at least go deeper into the topic of pain and addiction\u2013rather than just raising that scary reality and not explaining it better.", "answer": 1}, {"article": "\"You start doing research on that type of tumor, and you're saying, 'Oh my God, you're history.'\nStill, he cautions that the targeted treatments can't be considered cures.\nKnowing more about the genetic mutations of a tumor enables doctors to find a potentially effective drug much more quickly and accurately.\nOur series is produced with member station WNYC, and with Ken Burns Presents: Cancer: The Emperor of All Maladies, which will air on PBS starting March 30.\nCalled a basket trial, the study is designed to include people whose tumors have the same kind of genetic fingerprint regardless of where in the body the tumors are found.\n", "question": "Does the story commit disease-mongering?", "explanation": "The opening quote from the patient profiled in this story is dramatic:\u201d\u2018Oh my God, you\u2019re history.\u2019 It\u2019s like a death sentence.\u201d \u00a0Given the poor survival statistics associated with this type of cancer, that type of reaction is certainly understandable. But if a story is going to lead with an alarming statement like that, we\u2019d also expect it to provide some backing in the form of dispassionate, evidence-based figures about survival. Otherwise it\u2019s not clear whether patients typically have weeks or years to live following a diagnosis.", "answer": 0}, {"article": "And sometimes we have to make decisions about using drugs that are probably a little less effective but at the same time we have to take into account the financial standpoint,\" said Dr. Jay Brooks, chairman of hematology/oncology at Ochsner Health System in Baton Rouge.\nRead the full guideline at the American Society of Clinical Oncology.\nThe new guidelines replace previous guidelines issued in 2002, and subsequent updates in 2003 and 2004.\nAromatase inhibitors are not effective in this age group, the experts note.\nCrystal Denlinger, assistant professor of medical oncology at Fox Chase Cancer Center in Philadelphia.\n", "question": "Does the story commit disease-mongering?", "explanation": "", "answer": 1}, {"article": "\"It's clear that these medications are beneficial,\" said Wadden, who has been a paid consultant to pharmaceutical companies as well as Weight Watchers. \"Unfortunately, there's a sense that they must not work if you have to take them indefinitely. But I think obesity medications should be used on a long-term basis for chronic weight management, just as I take a [cholesterol-lowering] statin and a blood-pressure medication for the long term.\"", "question": "Does the story commit disease-mongering?", "explanation": "There was no disease mongering in the piece. Instead, there was an explanation about the state of the obesity problem in the U.S. and the resulting health consequences.\nOn a related note, we must say that we would prefer that news outlets not use the term \u201cfat\u201d in referring to people who are overweight, which this story did. It has a pejorative sting to it that is no different than referring to kids who don\u2019t graduate from high school as \u201cdumb\u201d or people who suffer from alcoholism as \u201cdrunks.\u201d", "answer": 1}, {"article": "In particular, it measures rhythmic patterns known as theta and beta waves.\nHe wasn't doing his homework.\nAnd that research appears to be on the way.\nBut other children got a placebo -- a race car that paid no attention to their brain waves.\n\"The improvement I saw was that he was easier to live with.\"\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease-mongering in this story.", "answer": 1}, {"article": "\"We are not going to reverse any of the chronic diseases in this country by changing the composition of the diet,\" Dr. Howard said.\nWomen were told to aim for a diet that had just 20 percent of its calories as fat, and most fell short.\nCorrection: February 16, 2006, Thursday A front-page article on Feb. 8 about a new study finding that low-fat diets have no effect on the risk of cancer or heart disease misstated the incidence of breast cancer among women in the study.\nStudies of dietary fiber and colon cancer failed to find that fiber was protective, and studies of vitamins thought to protect against cancer failed to show an effect.\nSome medical specialists emphasized that the study did not mean people should abandon low-fat diets.\n", "question": "Does the story commit disease-mongering?", "explanation": "", "answer": 1}, {"article": "The 1,788 who continued statins up to the day of surgery had a risk of death within 30 days of 1.7 percent, compared with 2.9 percent for 452 who stopped one to three days before surgery, and 3.8 percent for 781 who did not take statins or stopped more than 72 hours before their operations.\nThe scientists had no data on how long patients had been taking statins, but only on when they stopped.\n\u201cWe already knew that people on statins before surgery had a decreased risk of death,\u201d said a co-author, Dr. Yi Deng, an assistant professor of anesthesiology at Baylor College of Medicine.\nResearchers looked at 3,021 heart surgery patients, most of whom were taking cholesterol-lowering statins.\nAfter controlling for many preoperative health and behavioral characteristics, they found that compared with other patients, those who took statins on the day of surgery had a 48 percent reduced risk of dying in the next 30 days.\n", "question": "Does the story commit disease-mongering?", "explanation": "There is no disease mongering in the story. Heart surgery is a common procedure, and while generally also a safe one, it still carries risks, which is why this new data is relevant and interesting.", "answer": 1}, {"article": "Clostridium novyi flourishes in low-oxygen environments.\nHowever, Janku said this could be an underestimate since the infection causes surrounding tissue to become inflamed, making the lesion appear larger than it actually is.\nResearchers have moved on to the next phase, in which patients taking the immunotherapy drug pembrolizumab (Keytruda) will also be treated with a single injection of Clostridium novyi-NT, Janku said.\nA potentially dangerous bacteria appears to target malignant cells and could provide a new means of fighting cancer, a small, preliminary study reports.\nPatients in this clinical trial were left with the bacterial infection for one week, and then everyone was given antibiotics to kill off the Clostridium novyi-NT, Janku said.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story does not engage in disease-mongering. It would have been helpful to discuss how many people have sarcomas, the type of cancer most patients in the trial had. According to the Sarcoma Alliance, there are about 15,000 new cases diagnosed annually in the U.S. There are also over 90,000 new cases of melanoma diagnosed annually.", "answer": 1}, {"article": "Both Prozac and Celexa belong to a class of antidepressants known as selective serotonin reuptake inhibitors, or SSRIs.\n\u201cIt takes the edge off,\u201d Hollander explains, noting that the findings were statistically significant and clinically meaningful.\nWhen the research was originally funded, Hollander says, autism was considered to be a rare condition.\n\u201cRepetitive behavior is a core symptom of the illness,\u201d says lead author Dr. Eric Hollander, medical director of the Autism and Obsessive-Compulsive Spectrum Program at Montefiore Medical Center in New York, explaining that \u201cfrom a very early age, these children have rituals and routines.\nThe study was published in the American Journal of Psychiatry.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story does not engage in disease mongering but it could have provided a little more detail about the differences between Asperger\u2019s syndrome and other forms of autism.\n\u00a0\n\u00a0", "answer": 1}, {"article": "A more invasive stem cell delivery technique has been showing positive results in other clinical trials, involving injecting patients' own stem cells directly into heart muscle.\nHe was not involved in the study.\nThis method of intravenous injection means that the procedure theoretically could be performed in a doctor's office or clinic, increasing the accesibility to patients, Karp said.\nThe phase I results from 53 patients are not definitive proof that the treatment is effective, but do suggest so, Hare said.\nThe research, published in the Journal of the American College of Cardiology, were part of a phase I study that set out to show safety.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story does nothing to exaggerate the prevalence or severity of the damage to the heart muscle by heart attacks. ", "answer": 1}, {"article": "We keep them at that temperature for the first 24 hours, at which time we re-warm them,\" Likosky explains.\nIt requires training and a lot of coordination.\nIt's a story that still gives Cowles chills.\nWhen 57-year-old Dean Cowles suddenly suffered a heart attack, he was lucky that he worked at a company that made defibrillators,reports.\n\"It should be more widely used.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story did not overtly engage in disease mongering.", "answer": 1}, {"article": "Probabilities may not grab all patients by the collar. But telling someone he or she has a better than 1-in-3 chance of dying before the next decade's out (or even a better than 1-in-10 chance) would probably be a sobering reminder to hit the gym. The authors said the metric \"can be used to communicate fitness-related risk and motivate behavioral change after exercise stress testing.\"", "question": "Does the story commit disease-mongering?", "explanation": "This story did not engage in disease mongering.", "answer": 1}, {"article": "According to traditional medicine, specific acupuncture points on the skin are connected to internal pathways that conduct energy, or qi (\u201cchee\u201d), and stimulating these points with a fine needle promotes the healthy flow of qi.\nThe study, which followed 150 pregnant women with major depression, tested \u201cdepression-specific\u201d acupuncture against massage and acupuncture sessions that, according to traditional Chinese medicine, does not specifically target depression.\n\u201cThe acupuncture protocol we have tested appears effective,\u201d lead researcher Dr. Rachel Manber, of Stanford University in California, told Reuters Health in an email.\nIt is unclear, Manber said, why acupuncture might help lessen the severity of depression.\nAll completed a standard measure of depression severity at the outset and again after four and eight weeks of treatment.\n", "question": "Does the story commit disease-mongering?", "explanation": "This story included data indicating that 3-5% of pregnant women are diagnosed with depression.", "answer": 1}, {"article": "The Department of Nutrition, Exercise and Sports conducts research, education, innovation, and dissemination of information in nutrition, human physiology and sports at the highest international level, and incorporates the humanities as well as health and social sciences.\nThese diets could also be effective independent of caloric restriction.\nThe different studies (six in total) employed a variety of nutrition strategies, including caloric restriction and ad libitum diets, varying the contributions of carbohydrate and fat, and increasing fiber intake.\nThe latest findings, as reported in AJCN, have garnered international support with further analysis conducted by researchers from the University of Colorado, Tufts University, and Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Fisiopatolog\u00eda de la Obesidad y Nutrici\u00f3n (CIBER OBN).\nWhile we are looking into other biomarkers, it is quite amazing how much more we can do for our patients just by using those two simple biomarkers.\n", "question": "Does the news release commit disease-mongering?", "explanation": "No disease mongering is evident in this release.", "answer": 1}, {"article": "\"It is not inconceivable that in the near future you will see the I-Portal goggle used on every sideline in America,\" Hoffer said.\nThe research findings published by PLOS ONE help support their objective.\nThe results of the trial met the expectations of Hoffer and his team of researchers.\nWith these findings, it appears the I-Portal goggle may be a solution.\n\"This work opens the door for site of injury testing and access to physiologic tests for athletes of all ages.\"\n", "question": "Does the news release commit disease-mongering?", "explanation": "There is no disease mongering in this news release.", "answer": 1}, {"article": "New research shows that resistance training protects the brain in persons with multiple sclerosis, which may delay the development of the disease\n\nIn the past, multiple sclerosis patients were advised not to exercise for fear of exacerbating the illness.\nA bigger and more in-depth on-going study will help to clarify this, and may also lead to improved treatment options, says Ulrik Dalgas.\nThis is the main finding of a study conducted by a research partnership between Aarhus University, Aarhus University Hospital, the University of Southern Denmark and the University Medical Center Hamburg-Eppendorf, that has just been published in Multiple Sclerosis Journal.\nHowever, he stresses that the aim is not to replace medication with physical training.\n\"Phasing out drugs in favour of training is not realistic.\n", "question": "Does the news release commit disease-mongering?", "explanation": "There is no disease mongering in the news release.", "answer": 1}, {"article": "Of those 40 women, 26 had mutations carrying low to moderate risk of breast or ovarian cancer, eight had mutations associated with Lynch syndrome, which increases colon and ovarian cancer risk, and three had high-risk breast cancer genes.\nMost of the women had a personal history of breast or ovarian cancer already.\nBut new tests for breast cancer risk mutations beyond the well-known BRCA genes would offer actionable information for many women and their doctors, a new study finds.\nAnd for many, family testing would be recommended for first-degree relatives, according to the report in JAMA Oncology.\nEven among all appropriate candidates who are sent for genetic testing, only nine percent will test positive for the BRCA mutations, so an additional four percent who have non-BRCA mutations is a significant number, Ellisen said.\n", "question": "Does the story commit disease-mongering?", "explanation": "There was no disease mongering here. Breast cancer is a real concern to many women.", "answer": 1}, {"article": "In the United States, about 10 percent of people say they have chronic insomnia, according to the U.S. Centers for Disease Control and Prevention.\nThere was still a benefit four weeks later.\nOne day on suvorexant boosted that by anywhere from 5 percent to 13 percent, relative to the placebo.\nIt's promising news, Bazil added, that there were no serious side effects in this study.\nThey had their sleep monitored in a sleep lab on their first night with each treatment, and then came back again after four weeks.\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease mongering of insomnia.", "answer": 1}, {"article": "\u201cWe recommend whole fruit and not fruit juice,\u201d says Farvid, \u201cbecause maybe one of the most important ways that fruit decreases risk of breast cancer is through fiber, and even natural fruit juice often has no fiber in it.\u201d\n\nIn another study also published in the , a separate group of researchers found that among 22,000 Danish women, those who added two alcoholic drinks a day on average increased their risk of developing breast cancer by 30% over five years.\nMORE: Mediterranean Diet With Olive Oil Linked to Lower Breast Cancer Risk\n\n\u201cThis study underscores the importance of what a young girl eats for her future health,\u201d says Farvid.\nThe findings are among the first to look at how diet during adolescence can affect health later, and highlights the importance of establishing healthy habits from a young age, especially since many of the chronic diseases occur over many years and get rooted early in life.\nThe results also underscore the importance of eating whole fruit, rather than fruit juice.\nAbout half of the 90,000 women who participated in the Nurses\u2019 Health Study also answered questions about their typical diet while they were teens.\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease mongering here.", "answer": 1}, {"article": "Still, the company, which already tests DNA for other health risks as well as ancestry, said this cancer test is \"a step in the right direction.\"\nThat accounts for a small percentage of people.\nBreast cancer test kits by genetic testing company 23andMe just received Food and Drug Administration approval.\nThe prescription-free test is the first to report on three specific BRCA1 and BRCA2 breast cancer gene mutations, according to the FDA.\n\u201cThe test should not be used as a substitute for seeing your doctor for cancer screenings or counseling on genetic and lifestyle factors that can increase or decrease cancer risk,\u201d he said.\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease mongering here.", "answer": 1}, {"article": "More than half of people who took Xyrem reported at least a 30% improvement in pain, says Kim Dupree Jones, PhD, of Oregon Health & Science University in Portland.\nXyrem also helped reduce fatigue, stiffness, and other symptoms, she tells WebMD.\nXyrem, which is approved by the FDA for the treatment of narcolepsy, corrects the same disturbed sleep patterns that studies have shown are common in fibromyalgia patients, Jones says.\nThe new study was presented at the annual meeting of the American Pain Society.\nMay 12, 2010 (Baltimore) -- The powerful sleeping medication Xyrem can help relieve the hallmark symptom of pain in people with fibromyalgia, suggests a study that pitted the drug against a placebo.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story cites an\u00a0advocacy group\u2019s estimate of prevalence\u00a0at 10 million.\u00a0We\u2019ve been unable to find a primary source for that estimate on the advocacy group\u2019s website. A more objective source,\u00a02008 published estimates,\u00a0suggested a prevalence closer to 5 million. However, given the difficulty in obtaining accurate prevalence information for this disease, we don\u2019t think there\u2019s evidence of disease-mongering.", "answer": 1}, {"article": "Fish like salmon, herring and sardine are a common source of EPA-DHA, while ALA is found in vegetables including soybeans, flax seeds and walnuts.\nDoctors, however, are unlikely to rush to change clinical practice.\nDiabetes patients also showed a possible benefit.\nDaan Kromhout of Wageningen University, who led the study, told the European Society of Cardiology the lack of efficacy might reflect the good background drug treatment patients were receiving, with 85 percent on cholesterol-lowering statins, as well as blood pressure and blood-thinning tablets.\nThe margarines used in the study were developed for the researchers by food and consumer goods giant Unilever.\n", "question": "Does the story commit disease-mongering?", "explanation": "\u00a0The story did not engage in overt disease mongering.", "answer": 1}, {"article": "The U.S. National Institute of Neurological Disorders and Stroke has more about autism.\nTwo experts agreed that early intervention is key.\nHe was cautiously optimistic about the promise of the video feedback approach.\nThe goal of the therapy -- delivered over five months while the infants were ages 7 to 10 months -- was to improve the infant's attention, communication, early language development, and social engagement.\nOther families were assigned to a control group that received no therapy.\n", "question": "Does the story commit disease-mongering?", "explanation": "When a story fails to give adequate description of the study group, as mentioned above, then it actually didn\u2019t even provide enough detail to be given any credit for avoiding disease mongering. The best such a story can be graded is N/A.", "answer": 2}, {"article": "A three-year-old Silicon Valley start-up, Counsyl Inc., won the Bronze Innovation Award for its simple, low-cost genetic test that can alert prospective parents who might be carrying genes that could cause hereditary diseases in their children.\n\nCounsyl's technology promises a \"high quality-of-life impact for families at risk for conceiving children with familial diseases,\" says Larry Bock, an Innovation Awards judge and special limited partner at venture firm Lux Capital. \"This technology bundles previously...", "question": "Does the story commit disease-mongering?", "explanation": "The story does avoid disease-mongering by presenting the new test as a useful and practical advancement without making any heart-wrenching claims about any of the disorders a child may inherit. In our view, this is a shortcoming. How many children are born each year with genetic diseases? That would be telling information, but the story does not provide it. We do get a different statistic \u2013 that approximately 20 percent to 30 percent of infant deaths are due to genetic diseases. This is interesting, and worth including, but it gets at only a part of the picture.", "answer": 1}, {"article": "Drinks such as POM have become increasingly popular with consumers in recent years, thanks in part to public health campaigns against soda that have been prompted by the obesity epidemic.\nBut that doesn't mean the claims are invented -- most are based in research.\nMost health beverage drinkers aren't as enthusiastic as the realtor from Alaska who posted the above testimonial.\nHowever far-fetched the claims may sound, POM is standing behind them.\nThat's the paradox of products such as POM, Silverglade says: The health claims on these products strain the imagination, yet studies have repeatedly shown that health claims sell food.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story doesn\u2019t exaggerate any of the conditions POM supposedly prevents or treats.", "answer": 1}, {"article": "And finally, this is a very real world study.\u201d\n\nThe study was received well by the audience.\nReduction in high blood pressure has added health benefits because it can potentially reduce the likelihood of heart attacks, strokes, chronic heart failure and kidney disease.\nIn 2013, high blood pressure was the major cause behind 360,000 deaths in the United States.\nHigh blood pressure affects 1 in every 3 adults in the United States, according to a fact sheet by the Centers for Disease Control and Prevention.\nOne of the caveats of the study was that participants were highly motivated people looking for ways to cope with and decrease their blood pressure.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story does a good job of establishing how prevalent this condition is, and why new interventions are a good thing:\nHigh blood pressure affects 1 in every 3 adults in the United States, according to a fact sheet\u00a0by the Centers for Disease Control and Prevention. In 2013, high blood pressure was the major cause\u00a0behind 360,000 deaths in the United States. Reduction in high blood pressure has added health benefits because it can potentially reduce the likelihood of\u00a0heart attacks, strokes, chronic heart failure and kidney disease.", "answer": 1}, {"article": "A type of sleeping pill that several major pharmaceutical companies are racing to develop received good news yesterday when Swiss biotech company Actelion Ltd. reported positive clinical data.\n\nSleep experts say the drug class needs further study but could potentially offer some benefits beyond Ambien, the top-selling drug in the $3.8 billion global market for sleeping pills. While Ambien and similar drugs, called nonbenzodiazepine drugs, are effective and easily tolerated by most people, some insomniacs don't respond to the...", "question": "Does the story commit disease-mongering?", "explanation": "The story did not engage in overt disease mongering.", "answer": 1}, {"article": "Publicity in recent years about emotional, cognitive, and memory problems in aging football and hockey players who suffered multiple concussions during their careers has raised the anxiety level around the topic. A lawsuit by thousands of NFL players who claim the league did not keep them well enough informed about the long-term risks of concussion - dementia is one of them - is based in Philadelphia and has raised even higher the profile of what doctors call mild traumatic brain injury.", "question": "Does the story commit disease-mongering?", "explanation": "No disease mongering in the story.\nIf anything, the story missed a chance to explain that according to the CDC, almost half a million emergency department visits for concussions and other traumatic brain injuries are made annually by children aged 0 to 14 years.", "answer": 1}, {"article": "\"We can get that whole process of what a meal does without actually having the meal,\" he said.\nThe paper suggests that the drug may one day offer a nonsurgical alternative to \"vertical sleeve gastrectomies\" that have become popular in the battle against morbid obesity.\nExperts rightfully caution against relying on miracle diet drugs, but a new study offers a novel approach that bears watching.\nResearchers at the Salk Institute for Biological Studies in La Jolla, Calif., reported Monday that they have developed a compound that tricks the metabolism into responding as if a meal has been eaten, causing it to burn fat to make room for new calories.\nThe study also found other benefits.\n", "question": "Does the story commit disease-mongering?", "explanation": "Obesity is a serious health issue. The story mentions that this drug might be an alternative to surgery for people who are morbidly obese.", "answer": 1}, {"article": "Among its raft of recommendations, the consensus statement says that:\n\u2022 Should aim to play for 150 minutes/week, or do less, but couple golf with other physical activity, and walk the course rather than ride a golf cart\n\u2022 Do warm-up/strengthening exercises to cut the risk of injury and use sun-cream and wear collared shirts/blouses to minimise the risk of skin cancer\n\u2022 Build on existing initiatives to promote inclusivity and develop environments and price structures that will be attractive to everyone\n\u2022 Develop a culture that will inspire more women and girls to play golf\n\u2022 Make every effort to promote equality and diversity, and boost accessibility\n\u2022 Promote sustainability through wildlife conservation and by restricting the use of water, energy, and pesticides\n\u2022 Provide additional facilities at clubs, such as a gym, walking routes, cr\u00e8ches and improve the focus on health and safety, with the provision of healthy foods, defibrillators, and speed limiters on golf carts, for example\n\u2022 Promote the benefits of regular physical activity, including golf, for people of all ages, genders, and income brackets\n\u2022 Work with industry and national associations to boost take up of the sport, particularly in groups where physical activity levels are low\n\u2022 Work with industry and regulatory bodies to get golf included in the Paralympics\n\n\"These outputs, if widely shared and adopted, will contribute to an improved understanding of golf and health, and aid these groups in making evidence-informed decisions and to improve health and wellbeing,\" the consensus statement concludes.\nThis can put people off, says the statement.\nAgreement was reached on 79 statements in three areas.\nAnd it can boost older people's strength and balance.\nEvidence suggests it may not only be good for mind and body, but also for a long life\n\nThe consensus--one of the first of its kind--comes on the eve of the Ryder Cup, the biennial golf tournament between Europe and the US.\n", "question": "Does the news release commit disease-mongering?", "explanation": "No disease mongering noted.", "answer": 1}, {"article": "\"We showed for the first time that a regular intake of substances that are naturally present in red-, blue-colored fruits and vegetables can reduce the risk of a heart attack by about 32 percent in young and middle-aged women [ages mid-40s to 60],\" compared with women who ate berries once a month or less, says study author Aedin Cassidy of the University of East Anglia.\nEckel says it's not clear.\nSo, go ahead.\nBut he says it's important to point out that the women in this study weren't prime candidates for heart attacks anyway.\nAnd when you eat a steady diet of them, they seem to have a number of positive health effects.\n", "question": "Does the story commit disease-mongering?", "explanation": "There is no disease mongering.", "answer": 1}, {"article": "The apolipoprotein gene is inherited from each parent and when a patient inherits the ApoE4 variant from one parent they have a three times greater risk of developing Alzheimer's disease, whereas a patient who inherits ApoE4 from both parents is eight-to-12 times more likely to develop the disease.\n\"This fast, accurate testing will allow doctors and patients to make more informed choices earlier to potentially slow the possible progress of Alzheimer's.\"\nFor more information, visit www.aacc.org.\n\"Higher FT4 or TSH Below the Normal Range are Associated with an Increased Risk of Dementia: a Meta-analysis of 10 Studies\" (A-180)\n\nSession Information \n\nRegistration for the AACC Annual Scientific Meeting is free for members of the media.\n\"Pairing this test with medical and family history for risk of Alzheimer's disease has the real potential to advance personalized medicine,\" said Harte.\n", "question": "Does the news release commit disease-mongering?", "explanation": "No mongering here.", "answer": 1}, {"article": "\"I hear a lot of moms say, 'I'm disappointed I had to have a C-section.'\nCamann says the gentle C-section is not a replacement for a vaginal birth; it's just a way to improve the surgical experience.\nBetsey Snow of Anne Arundel Medical Center says the family-centered C-section represents a cultural shift, and her hospital is helping break new ground by adopting it.\nChanges like this can make a big difference, says Dr. William Camann, the director of obstetric anesthesiology at Brigham and Women's Hospital in Boston and one of the pioneers of the procedure in the U.S. At Brigham and Women's, their version of the family-centered cesarean is called the gentle cesarean.\nIn addition, Penn says, the mother's hands were not strapped down and the intravenous line was put in her nondominant hand so she could hold the baby.\n", "question": "Does the story commit disease-mongering?", "explanation": "There is potential for disease-mongering in the concept of the family-centered C-section. If it ends up increasing the number of women who deliver surgically instead of vaginally, then that would represent a further unnecessary medicalization of the birth process. However, the story specifically quotes an expert who says that\u2019s not something advocates are looking for: \u201cNo one is trying to advocate for C-sections. We really don\u2019t want to increase the cesarean rate, we just want to make it better for those who have to have it.\u201d\nWhile that\u2019s a useful sentiment, we think it would have been helpful for the story to explicitly acknowledge the problem of high cesarean birth rates in the U.S. compared with other economically advanced nations.", "answer": 1}, {"article": "The study found that 78 percent of patients reported being pain-free or having adequate relief within 15 minutes of receiving high-flow oxygen, compared with 20 percent of patients after they received high-flow air.\nTUESDAY, Dec. 8, 2009 (HealthDay News) -- High-flow oxygen appears to be an effective treatment for cluster headaches, British researchers have found.\nThe National Pain Foundation has more about cluster headache.\n\"This work paves the way for further studies to optimize the administration of oxygen and its more widespread use as an acute attack treatment in cluster headache, offering an evidence-based alternative to those who cannot take triptan agents,\" they concluded.\nNo serious harmful side effects were reported after high-flow oxygen treatment, according to the report published in the Dec. 9 issue of the Journal of the American Medical Association.\n", "question": "Does the story commit disease-mongering?", "explanation": "There isn\u2019t any disease mongering in the story, but there also isn\u2019t any information provided about the prevalence of cluster headaches, nor of the proportion of all headaches that they represent.\u00a0 The reader therefore may have a hard time identifying the importance or applicability of this treatment.", "answer": 1}, {"article": "Most guidelines set forth by the major medical groups suggest starting a patient with an ACE inhibitor first, but the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC) considers ACE inhibitors and ARBs to be equal.\nThat inconsistency created a confusing split in the medical community.\nIf there really was such a big difference between the medications, why didn't it show up in these types of studies?\nBut some doctors and researchers were puzzled by the fact that in head-to-head comparisons between the two classes of drugs they appeared to equally safe and effective.\nIf your risk is lower it's harder to show a benefit.\"\n", "question": "Does the story commit disease-mongering?", "explanation": "The story does not appear to commit disease-mongering.", "answer": 1}, {"article": "The researchers believe that adding probiotics to the peanut allergens may be important in improving the children\u2019s tolerance to the food, but Dr. Anna Nowak-Wegrzyn, an associate professor of pediatrics at Icahn School of Medicine at Mt.\nBut it may be too early to call this a cure.\nThe Australian team added probiotics to further enhance the gut\u2019s ability to accept the peanuts and not trigger an immune reaction.\nThe results are encouraging, allowing the children who were treated to eat peanuts without fear of an allergic reaction.\nPrevious studies have suggested that methods like these could be effective in reducing youngsters\u2019 allergic, sometimes dangerous anaphylactic shock reactions to peanuts.\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease mongering here.", "answer": 1}, {"article": "\"Those stem cells are given back to the patient where they can go back to the bone marrow and make the blood cells for the rest of the patient's life,\" Kohn said.\nThat means an actual cure for the disease, said Kohn, who is also director of the Human Gene Medicine Program at UCLA.\nDr. Kohn is currently working with the FDA to make his treatment available nationwide.\nDr. Kohn said of an experimental treatment for SCID, \"It's gone from a 'one day, maybe' to a real clinical reality.\"\nClinical trials for that treatment are now underway.\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease mongering is evident here. However, this\u00a0disease is serious and often fatal. There could have been more information provided such as the average life expectancy without treatment and with alternative treatments, to put the disease in context and not just say it is serious.", "answer": 1}, {"article": "At 12 months in patients receiving torcetrapib, there was a 72 percent increased in good cholesterol and a 24.9 percent decrease in bad cholesterol.\nThe study said there were still many unanswered questions about Pfizer's pill, torcetrapib, the first in a new class of heart medicines known as a CETP inhibitors, which raise HDL, or good cholesterol, and lower LDL, or bad cholesterol.\nIt was unclear what the mixed bag of data presented at the American Heart Association's Scientific Session in Orlando would mean for CETP drugs under development by Merck and Roche, and another candidate in early-stage development by Pfizer.\nA long-awaited postmortem released this morning of Pfizer's (NYSE: PFE) failed heart drug held out hope for the discovery of a safe version of the revolutionary heart pill.\n\"In any case, it is premature to announce the death of CETP inhibitors on the bases of the torcetrapib experience alone.\"\n", "question": "Does the story commit disease-mongering?", "explanation": "The story does not exaggerate the seriousness or prevalence of heart disease, the target of the new drug. However, the story could have done more to point out that many researchers are now questioning the HDL/heart disease hypothesis.", "answer": 1}, {"article": "In a third type of weight-loss procedure, known as sleeve gastrectomy, surgeons remove part of the stomach.\nMore of those undergoing lap-banding, however, needed repeat surgeries (13 percent vs. 2 percent).\nMore people in the bypass group had complications right after the surgery.\nGastric bypass is considered riskier and more technically demanding than the band.\nAn editorial accompanying the studies noted the results should be interpreted with caution since longer-term data is not yet available.\n", "question": "Does the story commit disease-mongering?", "explanation": "No disease-mongering here.", "answer": 1}, {"article": "\"Now they tell me, 'You never say 'What?'\nThe condition is caused by damage to the inner ear or to nerves from the inner ear to the brain.\nOften, it meant only being able to do one thing at a time, explained the mother of three young children.\nThe implant is permanent.\nFor patients with profound hearing loss, a cochlear implant is a better option, he said.\n", "question": "Does the story commit disease-mongering?", "explanation": "The article does not provide much information on the conditions leading to damage to the inner ear, or to nerves from the inner ear to the brain. More background and context on these disorders would have been welcome in this case.", "answer": 1}, {"article": "People interested in the procedure can learn more at uvahealth.com/focusedultrasound.\nThe procedure is not for everyone with essential tremor.\nParticipants who received the treatment showed dramatic improvement, with the beneficial effects continuing throughout the study period.\nParticipants who received the sham procedure, on the other hand, showed no significant improvements.\nThe essential tremor research has been supported by InSightec, the Focused Ultrasound Foundation and the BIRD (US-Israel Binational Industry Research and Development) Foundation.\n", "question": "Does the news release commit disease-mongering?", "explanation": "The release does not appear to disease-monger.", "answer": 1}, {"article": "The studies suggest that fewer physicians are recommending annual mammograms for women in their 40s, fewer patients in that age group are getting screened and that tumors found through routine mammography are more likely to be detected in early stages of cancer.\nWho decides about mammograms?\nBreast cancer ID'd more accurately by docs who see more scans\n\nPlecha's findings were not surprising to Moyer.\nThe task force did not say don't get mammograms, Moyer said.\n\"There is a real, but rather modest benefit.\n", "question": "Does the story commit disease-mongering?", "explanation": "No overt disease-mongering.", "answer": 1}, {"article": "Normal metabolizers of nicotine, meanwhile, had more success with varenicline because they tend to rid their systems of nicotine faster, limiting the effectiveness of the patch.\nAbout 70 percent of smokers give up the daunting effort during the first week of trying.\nAnd given how difficult it is to kick the habit, smokers need all the help they can get to succeed the first time they try, Lerman said.\nThis may seem like common sense, but no one had ever tested it before, she said.\n\"The trial and error approach is not optimal.\"\n", "question": "Does the story commit disease-mongering?", "explanation": "The story did not exaggerate the dangers of smoking.", "answer": 1}, {"article": "\"The question was to see if more weight loss could be achieved if we provided decent quality lifestyle intervention, mostly dietary counseling, along with this medication,\" said study lead author Dr. Kishore Gadde, director of the Obesity Clinical Trials Program at Duke University Medical Center in Durham, N.C.\n\n\"And the answer was yes,\" Gadde said.\nCaution is vital when using any drug that has been approved for one condition for another, Sandon said.\nThe research, funded by the U.S. National Institutes of Health, appears online Oct. 15 in the journal Archives of Internal Medicine.\nNone had diabetes.\nPsychological factors or lifestyle factors may play a role, he said.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story does not engage in disease mongering.", "answer": 1}, {"article": "\"So before we activated the device, we have all sorts of problems\u2026 This is basically your brain saying, 'I'm not breathing.'\nA treatment is offering hope for millions of patients with sleep apnea, a disorder that causes people to stop breathing when they're asleep.\nOn average, she stops breathing 53 times an hour, that's nearly once every minute during a night's sleep.\n\"And as far as I'm concerned, this is a cure.\nIt's only for moderate to severe cases, and like any surgery, there is risk of infection.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story only includes the perspective of one patient with very severe sleep apnea, but never clarifies how many people with sleep apnea have mild, moderate or severe sleep apnea. We\u2019re left to assume it\u2019s a whole heck of a lot of people, because the story says this new treatment \u201cis offering hope for millions of patients.\u201d This lack of clarity adds up to disease-mongering.", "answer": 0}, {"article": "Being around for my daughter, my son, my wife.\nAbout eight months after a single treatment, 39 percent of patients had no evidence of cancer.\nSandoval is alive today because of an experimental form of immunotherapy called CAR-T.\nOn Friday, Moffitt Cancer Center and MD Anderson reported test results of 101 patients with advanced lymphoma who had failed previous therapy and were treated with CAR-T.\n\n\u201cIt puts a GPS navigation on the front of the cell so that when they\u2019re infused back in they know where to go and kill the lymphoma,\u201d said Dr. Frederick Locke, who helped lead the trial.\n\u201cThat\u2019s actually quite remarkable knowing that at best only one out of 10 of these patients could have complete disappearance of their lymphoma with standard chemotherapy,\u201d Locke said.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story reports that the trial included patients with \u201cadvanced lymphoma who had failed previous therapy.\u201d\nHowever, the lack of detail could lead many readers to believe it applies to more lymphoma patients than just the B-cell non-Hodgkin lymphoma patients who had already undergone multiple prior treatment attempts.", "answer": 1}, {"article": "\"They do research online, are more informed and sometimes go to the doctor demanding, 'I think I need an MRI.'\nThere is just no single reason why people get chronic headaches, although we do know that migraines have a genetic component and usually a trigger.\nBut even a little can help, and according to Bernstein it doesn't have to be jogging for miles and miles.\nBernstein says she sees lots of desperate patients like Bradford.\nShe acknowledges it's sometimes difficult to encourage a patient with cracking head pain to get up and exercise.\n", "question": "Does the story commit disease-mongering?", "explanation": "We\u2019re flagging the story for several problems that collectively rise to the level of Not Satisfactory:\n1. The narrow focus on one patient\u2019s extreme experience with migraines compared to the lack of focus on any meaningful evidence about how to relieve migraine symptoms.\n2. The extrapolation of this one patient\u2019s experience to \u201c12 million Americans\u201d and then to \u201cone quarter of the population,\u201d which would be about 80 million people. This seems high, and there is no reference provided for the number.\n3. The anecdotal evidence presented as fact without any attempt to back it up. The story says:\nOver the years, Bradford, who is 50 years old and lives in Bedford, Mass., has searched desperately for pain relief. She\u2019s been to the doctor countless times for countless tests. \u201cEverything I\u2019ve had, I\u2019ve had twice,\u201d she says. \u201cI\u2019ve had two spinal taps; I\u2019ve had so many nerve blocks I\u2019ve lost count.\u201d\nHas she really been to the doctor so many times that it is impossible to count? This feels needlessly dramatic. Perhaps a walk through the woman\u2019s documented medical history would have supported the same point without that feeling of over-dramatization. Even well-meaning people can provide misleading information about their own medical histories, especially if a condition has been ongoing for years.\nThose three components make this story feel off-kilter, and take the focus off of the thoughtful exploration of potential solutions.", "answer": 0}, {"article": "These are moments that caregivers can cherish.\u201d\nPrevious research on communication in couples affected by Alzheimer\u2019s has tended to focus on deficits, said study author Christine Williams, professor and director of the PhD in Nursing program at Florida Atlantic University\u2019s Christine E. Lynn College of Nursing.\nA relationship is obviously so much more than that.\u201d\n\nMembers of Williams\u2019s research team visited 15 couples in their home once a week for 10 weeks.\n\u201cAt the same time, people with Alzheimer\u2019s do have moments of clarity or show affection when it\u2019s unexpected.\nYet Williams hopes that the more supportive and positive communication patterns that many of the caregivers showed will help nurses coach spouses and family members affected by Alzheimer\u2019s.\n", "question": "Does the story commit disease-mongering?", "explanation": "While Alzheimer\u2019s disease does carry some fear aspect among the public, this story does not seem to play on that fear but instead offers constructive ideas for maintaining communications within couples where one person has Alzheimer\u2019s. The statistics offered in the story seem to line up with those presented in this NIH fact sheet.", "answer": 1}, {"article": "\u2022 This is the first time tandospirone has be shown to reverse the deficit in brain neurogenesis induced by heavy alcohol consumption\n\u2022 The researchers also showed in mice that the drug was effective in stopping anxiety-like behaviours associated with alcohol withdrawal, and this was accompanied by a significant decrease in binge-like alcohol intake\n\n\"This is a novel discovery that tandospirone can reverse the deficit in neurogenesis caused by alcohol,\" said study leader neuroscientist Professor Selena Bartlett from QUT's Institute of Health and Biomedical Innovation.\nThe findings have been published in Scientific Reports.\nAlcohol is specifically very damaging for neurons.\nIt is commonly used there and shown to be highly effective in treating general anxiety and well tolerated with limited adverse effects.\"\n\"This opens the way to look at if neurogenesis is associated with other substance-abuse deficits, such as in memory and learning, and whether this compound can reverse these.\"\n", "question": "Does the news release commit disease-mongering?", "explanation": "The release does not appear to commit disease mongering.", "answer": 1}, {"article": "Sometimes, individuals with CDE have trouble opening their eyes, but Tomei said she went to the doctor and reported mild but incessant itchiness and dryness, and was diagnosed with CDE.\nOn Restasis.com, you can take the brand\u2019s \u201cdry eye quiz\u201d\u2014 for every quiz taken, Allergan has agreed to donate $1 to the organization.\nWhen you visit the website, you\u2019ll see a pop-up window with a portal to take the quiz.\nThe quiz on Restasis.com can help individuals learn whether they\u2019re a candidate for the drug.\nIf you think you may be suffering from CDE, Tomei advised visiting your doctor to receive a diagnosis.\n", "question": "Does the story commit disease-mongering?", "explanation": "This is pretty clearly as over-the-top\u00a0disease mongering as you\u2019ll find, and the helpful-sounding self-diagnostic questionnaire is a\u00a0huge red flag indicating that people are about to be turned into patients. Also, turning chronic dry eye into an acronym\u2013\u201cCDE\u201d\u2013elevates it to\u00a0medical jargon status.", "answer": 0}, {"article": "Get the facts.\nThe Gardasil vaccine, on the other hand, caused some people to faint after getting it, and others got mild skin infections\u2014both of which occur somewhat rarely with other vaccines too, as you might expect.\nThis, sadly, is expected; more than 178 million doses of Gardasil have been given worldwide, and given that huge number it\u2019s a statistical certainty that some young people will die not long after getting them.\nFor example, a young girl died tragically not long after getting the vaccine, and it got a lot of press, but it was later found that she died of a completely unrelated cause.\nIt\u2019s very frustrating; mounds of data show these vaccinations are incredibly low-risk, but it only takes a little bit of doubt and fear to make vaccine rates drop.\n", "question": "Does the story commit disease-mongering?", "explanation": "The story\u2019s assertion that cervical cancer causes 4,000 deaths each year in the United States is backed up by the Centers for Disease Control and Prevention. But that number doesn\u2019t really give much sense of one\u2019s overall lifetime risk of developing the disease and whether the disease is common or relatively rare. It would have been useful to know, comparatively, how common cervical cancer is and how it ranks in relation to other cancers.", "answer": 1}, {"article": "Unlike the 2012 campaign, which aired for 12 consecutive weeks, the 2014 campaign aired in two phases, from February 3 to April 6 and from July 7 to September 7.\nWith a year-round campaign we could save even more lives and money.\u201d\n\nTips, the first federally funded anti-smoking paid media campaign, features former smokers talking about their smoking-related illnesses.\nThe latest outcomes measuring the impact of CDC\u2019s national tobacco education campaign are as strong as those achieved in its first year, and suggest that three years into the campaign, the ads were still having a significant impact.\n\u201cThe money spent in one year on Tips is less than the amount the tobacco industry spends on advertising and promotion in just 3 days.\u201d\n\nThe most recent Surgeon General\u2019s Report, The Health Consequences of Smoking\u201450 Years of Progress, called for airing effective messages such as the Tips ads with high frequency and exposure for 12 months a year for a decade or more.\n\u201cThe Tips campaign is an important counter measure to the $1 million that the tobacco industry spends each hour on cigarette advertising and promotion,\u201d said Corinne Graffunder, Dr.P.H., director of CDC\u2019s Office on Smoking and Health.\n", "question": "Does the news release commit disease-mongering?", "explanation": "Normally, we ding releases or news stories that equate risk factors and health effects. There is, after all, a significant difference between the two. This release emphasizes the costs \u2014 both human and economic \u2014 of smoking, to the point of disease mongering. However, given the overwhelming abundance of research linking cigarette smoking to a wide array of severe health problems, we think this may be the exception to the rule. What keeps it on the satisfactory side is the language in the release highlighting smoking as a risk factor to cancer, stroke and other health problems.", "answer": 1}, {"article": "The FDA needs good data to make their decision, because when the agency approves a drug is sends a signal to the world.\n(The drug\u2019s brand name is Translarna.)\nTwo recently approved drugs have run into this problem: Spinraza, a drug for spinal muscular atrophy, and Exondys 51.\nBut the family\u2019s struggles with DMD were just beginning.\nDMD is one of a class of similar genetic disorders.\n", "question": "Does the story commit disease-mongering?", "explanation": "Duchenne muscular dystrophy is a killer.", "answer": 1}, {"article": "Doctors often recommend a \"watch and wait\" period for men with low-grade, or less aggressive, prostate tumors.\nThe study results were scheduled for presentation Monday at the annual meeting of the American Chemical Society in Denver.\nThe findings also need to be replicated in a much larger number of patients, D'Amico said.\nHowever, the study was small, and results from a larger trial aren't expected for several years, he added.\nD'Amico stressed that men should not start taking vitamin D supplements in hopes of slowing or curing prostate cancer.\n", "question": "Does the story commit disease-mongering?", "explanation": "No evidence of disease mongering.", "answer": 1}, {"article": "Side effects of male hormone therapy can include erectile dysfunction (impotence), loss of sex drive, hot flashes, growth of breast tissue, loss of muscle and bone mass, weight gain, nausea, liver problems, fatigue, memory problems and mood swings.\nThe hormone therapy started two months before radiation.\nHe noted that the radiation treatments in use today differ from those given in 1994 when the trial began.\nSo, that brings into question how much, if any, hormone therapy is needed, he added.\nThese findings are good news for some men, since the effects of short term of hormone therapy are reversible, D'Amico said.\n", "question": "Does the story commit disease-mongering?", "explanation": "This story did not engage in overt disease mongering.", "answer": 1}, {"article": "The results of the Women's Health Initiative (WHI)--the largest, most scientifically rigorous study of older women's medical issues ever conducted--continue to startle researchers, confuse the public and frustrate headline writers. Case in point: last week's report that taking estrogen for seven years does not increase the risk of breast cancer for many women. There is a lot of good news in that finding, as well as some important caveats.\n\nIn many ways, the story began four years ago when researchers halted a different part of the WHI--one that looked at the long-term health effects of taking the hormone combination estrogen and progestin...", "question": "Does the story commit disease-mongering?", "explanation": "No elements of disease mongering. Article clearly states that estrogen therapy is an option for treating severe menopause symptoms; it does not overstate the number of women entering menopause nor does it imply that they all will experience severe symptoms that warrant treatment.", "answer": 1}, {"article": "The requested URL /usnews/health/articles/070107/15downs.htm was not found on this server.", "question": "Does the story commit disease-mongering?", "explanation": "By accurately presenting the prevalence of Down syndrome, the story avoids disease mongering. However, the story devalues the quality of the lives of people with Down syndrome by implying that all women would want to know in advance in order to terminate the pregrancy.", "answer": 1}, {"article": "Some insurance plans cover EMDR.\nThe ordeal didn\u2019t end with the news of Nate\u2019s death.\nShe was finally able to remember the good times with her brother without being overwhelmed by pain.\nShe occupied herself with press inquiries and funeral arrangements.\nThis distraction had a positive effect on her, she said, allowing her to dive deeply into the therapy without freezing in the face of fear.\n", "question": "Does the story commit disease-mongering?", "explanation": "PTSD is a legitimate health issue that is difficult to treat. No disease mongering.", "answer": 1}, {"article": "The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices.\nOverall, participants who received Dupixent achieved greater response, defined as clear or almost clear skin, and experienced a reduction in itch after 16 weeks of treatment.\nDupixent\u2019s active ingredient is an antibody (dupilumab) that binds to a protein [interleukin-4 (IL-4) receptor alpha subunit (IL-4R )], that causes inflammation.\nThe safety and efficacy of Dupixent were established in three placebo-controlled clinical trials with a total of 2,119 adult participants with moderate-to-severe atopic dermatitis not adequately controlled by topical medication(s).\nThe FDA granted the application for Dupixent Priority Review and Breakthrough Therapy designation.\n", "question": "Does the news release commit disease-mongering?", "explanation": "The release does not engage in disease-mongering. Instead it offers a clear description of what eczema is and what causes the condition.", "answer": 1}, {"article": "The study, in The Journal of the Academy of Nutrition and Dietetics, found that those who ate the blueberry preparation saw an average 5.1 percent decrease in systolic blood pressure (the top number) and a 6.3 percent decrease in diastolic pressure.\nThere were no significant changes in the placebo group.\nThe improvement, the scientists write, was moderate compared with that of blood pressure medicines.\nMaybe.\nCan a cup of blueberries keep the doctor away?\n", "question": "Does the story commit disease-mongering?", "explanation": "High blood pressure affects the health of millions of Americans and people around the globe. No disease mongering here.", "answer": 1}, {"article": "\"There were times when I would yell at myself: 'I can't do this.\nIf made widely available, this kind of brain scan could be an important complement to the assessments -- based on reading and behavior -- already available for diagnosing dyslexia, Hoeft said.\nThis was another small study -- 20 dyslexic volunteers and 21 participants without the condition -- testing how people identify shapes, navigate a virtual environment, and do other tasks involving spatial reasoning.\nA study led by Fumiko Hoeft, psychiatry researcher at Stanford University School of Medicine, used brain imaging to answer this question.\n\"\n\nAbby and Davis, like an estimated 5 percent to 20 percent of the population, have struggled with dyslexia, a condition that, broadly speaking, hinders a person's ability to interpret language.\n", "question": "Does the story commit disease-mongering?", "explanation": "\n\n\nThe story refers to estimates that between 5 percent and 20 percent of the population has dyslexia. Unlike the Reuters story we also reviewed, this story provides a useful definition of dyslexia as \u201ca condition that, broadly speaking, hinders a person\u2019s ability to interpret language.\u201d", "answer": 1}, {"article": "Individuals with panic chronically hyperventilate, even when not experiencing a panic attack.\nFreespira is both easy to use and effective.\nTreatment is authorized and completed under the supervision of a licensed healthcare provider.\nTheir first product, Freespira, is an FDA-cleared treatment for individuals suffering from panic disorder, panic attacks and other symptoms of panic.\nAbout Freespira\n\nFreespira is an FDA-cleared, drug-free, four-week at-home treatment for panic attacks and other panic symptoms.\n", "question": "Does the news release commit disease-mongering?", "explanation": "There was no disease mongering.", "answer": 1}, {"article": "Dr Sheraz Markar, an NIHR Clinical Trials Fellow from Imperial College London, under the supervision of Professor George Hanna, told the Congress: \"At present the only way to diagnose oesophageal cancer or stomach cancer is with endoscopy.\nOver the next three years, the researchers will continue with a larger trial, using the test with patients who are being given an endoscopy for gastrointestinal symptoms but not yet diagnosed with cancer.\nThis will assess the ability of the test to pick up cases within a group that is likely to contain only a small percentage of cancers.\nThis study suggests that we may be able detect these differences and use a breath test to indicate which patients are likely to have cancer of the oesophagus and stomach, and which do not.\nThe new research, involving more than 300 patients, showed that the test could diagnose cancer with an overall accuracy of 85%.\n", "question": "Does the news release commit disease-mongering?", "explanation": "The release doesn\u2019t engage in disease mongering and provides statistics on the numbers of stomach and esophageal cancers diagnosed globally each year, which matches other sources, and this puts the disease in context for readers. But when it notes that these types of cancers have a low 5-year survival rate of 15%, it would have been better to also tell readers that, while deadly, these two cancers are relatively uncommon (accounting for less than 10% of cancer diagnoses even after excluding common, nonmelanoma skin cancer) and appear to be largely preventable through improvements in diet and other living conditions.", "answer": 1}, {"article": "Drs.\nAsher and Burri emphasize that the real importance of this study is its potential to make us think differently about what really matters in cancer therapy.\nThe trial authors concluded that the benefit of adding whole brain radiation was outweighed by its risks in patients with one to three newly diagnosed brain metastases.\nAsher and Burri, along with their co-investigators, now recommend that patients with one to three brain metastases should no longer receive routine whole brain radiation therapy, and should be treated with focused therapy alone to better preserve cognitive function and quality of life.\nThis is a very relevant finding, as over 200,000 patients still receive whole brain radiation in the United States each year, and the majority of patients with brain metastases have a limited number (typically three or less) of brain lesions.\n", "question": "Does the news release commit disease-mongering?", "explanation": "This ruling is a close call. Although the claim in the release that the study results could apply to tens of thousands of patients with brain tumors may be a reasonable estimate, it fails to put that number in context. The study included only a select group of patients with three or fewer metastases in their brains. By failing to mention either that one out of five patients in the trial died before the first post-treatment evaluation or that many patients with brain tumors don\u2019t match the description of those in the trial, readers are given an inflated sense of the relevance of these findings.", "answer": 1}, {"article": "Actually, nitrous is making a comeback in U.S. maternity circles. It has remained a staple of childbirth in Canada, Australia, and Britain \u2014 Catherine, Duchess of Cambridge (the former Kate Middleton), who welcomed her third royal baby, Louis Arthur Charles, last month, reportedly has used it. But it basically disappeared in the United States in the 1970s. American women preferred to be numbed below the waist with epidural anesthesia, or at least that became the gold standard for pain relief.", "question": "Does the story commit disease-mongering?", "explanation": "None.", "answer": 1}, {"article": "Viagra is one of three licensed drugs to treat erectile dysfunction, Davies explained. The other two are Cialis and Levitra. They can take from half an hour to several hours to work, and they're not for everyone: Men who've had a stroke or heart attack are told to use the drugs with caution, reports the Daily Mail. Even those without medical issues simply don't like the wait.", "question": "Does the story commit disease-mongering?", "explanation": "The story mentions \"the estimated 15 million American men suffering from erectile dysfunction.\"\u00a0 Whose estimate is that?\u00a0 What is it based on? Is this lumping together all men who have occasional problems with erections with those who have organic disease?\u00a0 ", "answer": 0}, {"article": "The findings are published in TheJournal of the American Medical Association.\nPrevious studies of other antidepressants have yielded mixed results, according to Freeman.\n''We believe escitalopram provides an option for treating moderate to severe hot flashes that are disrupting people's lives and quality of life,\" says study researcher Ellen Freeman, PhD, a research professor in the department of obstetrics-gynecology and psychiatry at the University of Pennsylvania School of Medicine, Philadelphia.\nThe new study findings suggest Lexapro can provide an option for women reluctant to take hormone therapy.\nIn the study, Freeman found the antidepressant reduced both the number and severity of hot flashes compared to placebo.\n", "question": "Does the story commit disease-mongering?", "explanation": "Menopause has been the subject of considerable disease mongering over the years \u2014 see here for some examples.\u00a0This story, though, confines the discussion to women whose symptoms are severe enough to disrupt their lives and quality of life. That seems to be a fair basis\u00a0upon which to\u00a0identify women who might be candidates for some kind of medical treatment of\u00a0menopause symptoms. The story could have\u00a0provided data on how many women suffer from moderate to severe hot flash symptoms, to give a better\u00a0idea of how widespread the problem is.", "answer": 1}, {"article": "The non-contact sports included were cheerleading, cross country, cycling, tennis and track.\nMore than one million athletes experience a concussion each year in the United States.\nThe American Academy of Neurology, an association of 30,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care.\nThe study found that the advanced version of TCD ultrasound was able to differentiate between healthy and concussed athletes 83 percent of the time.\nTCD uses ultrasound to map blood flow activity in the brain.\n", "question": "Does the news release commit disease-mongering?", "explanation": "The release doesn\u2019t engage in disease mongering. Concussions among athletes is an increasingly recognized health risk.", "answer": 1}, {"article": "Franks says thalidomide can help an additional 75% of patients achieve remission.\nThe researchers note that the study dose was \u201cgenerally well-tolerated.\u201d No new nerve symptoms were reported.\nThe lenalidomide study included 15 women with lupus skin conditions; six had lupus in other areas of the body, too.\nHe says about 75% of patients with affected skin will go into remission with these standard treatments.\nSimilar to treatment with thalidomide, most of the patients had a relapse of their skin problems within weeks of stopping the drug.\n", "question": "Does the story commit disease-mongering?", "explanation": "The article did not commit disease mongering. But it actually didn\u2019t provide enough background on lupus skin conditions to even be judged on this criterion.\nIt could have mentioned that this is an uncommon skin condition and that it is addressing the uncommon individual with this condition that doesn\u2019t respond to standard medications. That would have driven home point that the medication in question would be used very rarely.", "answer": 2}, {"article": "Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease.\nEating more healthy foods was the key, even if some unhealthy foods were also consumed along the way.\n2016.\nNow here\u2019s the interesting part: eating more foods thought to be less healthy \u2014 those typical of Western diets \u2014did not link to an increase in heart attacks, strokes, or deaths.\nThese findings held for every geographical region.\n", "question": "Does the story commit disease-mongering?", "explanation": "There was no disease mongering.", "answer": 1}]